zidovudine has been researched along with AIDS Seroconversion in 505 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 55 (10.89) | 18.7374 |
1990's | 356 (70.50) | 18.2507 |
2000's | 74 (14.65) | 29.6817 |
2010's | 15 (2.97) | 24.3611 |
2020's | 5 (0.99) | 2.80 |
Authors | Studies |
---|---|
Charoenphak, S; Nanthatanti, N; Sungkanuparph, S | 1 |
Aghokeng, A; Ateba Ndongo, F; Bilong, S; Djeuda, ABD; Eboumbou Moukoko, CE; Eyoum Bille, B; Fokam, J; Grace, N; Koki Ndombo, P; Moukoko Mbonjo, M; Ndjolo, A; Penda, CI | 1 |
Eleje, GU; Ikechebelu, JI; Nwagha, UI; Okafor, HU; Ugwu, AO; Ugwu, EO; Umeh, UA | 1 |
Domínguez-Castro, M; Figueroa-Damián, R; Galindo-Sevilla, N; Hernández-Pineda, J; Irles, C; Jung-Cook, HH; Katende-Kyenda, NL; Ramírez-Ramírez, A; Romo-Yañéz, J | 1 |
Abdool Karim, Q; Dawood, H; Mansoor, LE; Matten, D; Naicker, CL; Naidoo, K; Singo, D; Williamson, C | 1 |
Aling, E; Bbosa, N; Kaleebu, P; Kapaata, A; Kateete, DP; Lunkuse, S; Nabirye, SE; Nannyonjo, M; Nassolo, F; Nsubuga, RN; Omooja, J; Sanyu, G; Segujja, F; Ssebaggala, E; Ssemwanga, D | 1 |
Chasela, C; Ellington, SR; Hosseinipour, M; Hyde, L; Jamieson, DJ; Kayira, D; Kourtis, AP; van der Horst, C; Wiener, J | 1 |
Caprara, D; MacGillivray, SJ; Shah, R; Urquia, M; Yudin, MH | 1 |
Crowe, SM; David, M; Gare, J; Hearps, AC; Imara, U; Kaima, P; Kelly-Hanku, A; Kombati, Z; Ryan, CE; Siba, PM; Timbi, D | 1 |
Boissonnault, M; Charest, L; Galanakis, C; Huchet, E; Longpré, D; Machouf, N; Murphy, D; Thomas, R; Trottier, B; Vézina, S | 1 |
Asari, V; Baxter, C; Garrett, N; Grobler, A; Karim, QA; Karim, SSA; Majola, N; Naicker, N; Naidoo, A; Werner, L | 1 |
Chung, MH; John-Stewart, GC; Kiarie, JN; Kinuthia, J; Lehman, DA; Njiri, F; Overbaugh, J; Richardson, BA | 1 |
Boutté, P; Monpoux, F; Pitelet, G; Richelme, C | 1 |
Baxter, L; Bryant, J; Hird, S | 1 |
Averbuch, D; Engelhard, D; Jaouni, T; Pe'er, J | 1 |
Dia, AT; Diallo, PD; Gaye, AM; Sow, PG | 1 |
Atun, R; Ben-Smith, A; Chimbwandira, F; Chirwa, Z; Gilks, CF; Harries, AD; Jahn, A; Lynen, L; Makombe, SD; Meguid, T; Midiani, D; Mnthambala, A; Schouten, EJ; Shawa, M; Van Damme, W; van Oosterhout, JJ; Zachariah, R; Zolfo, M | 1 |
Henderson, DK | 1 |
Chidziva, E; Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Kizito, H; Kyomugisha, H; Munderi, P; Musoke, P; Nalumenya, R; Nathoo, K; Russell, EC; Spyer, M; Tumukunde, D; Walker, AS; Zalwango, E | 1 |
Colan, SD; Mittleman, MA; Oleske, JM; Patel, K; Seage, GR; Van Dyke, RB | 1 |
Capeau, J; Danner, SA; Domingo, P; Feeney, ER; Mallon, PW; Reiss, P; van Agtmael, MA; van Vonderen, MG; Villarroya, F; Wit, F | 1 |
Abimiku, A; Ajayi, S; Blattner, WA; Carr, JK; Chang, H; Charurat, M; Elegba, O; Etiebet, MA; Eyzaguirre, LM; Ndembi, N; Nowak, RG; Shepherd, J | 1 |
Bissek, AC; Defo, D; Kouotou, EA; Mboua, JB | 1 |
Aweeka, FT; Huang, L; Levy, JA; Liu, L; Siu, V; Teque, F; Wang, L | 1 |
Bonet Esteve, A; Jornet Montaña, S; Pérez Pons, JC | 1 |
Andréoletti, L; Bélec, L; Detmer, J; Kazatchkine, MD; Kolberg, J; Legoff, J; Matta, M; Mbopi-Kéou, FX; Piketty, C; Si-Mohamed, A | 1 |
Adungo, NI; Andayi, FA; Chemtai, AK; Kobayashi, N; Koech, DK; Lihana, RW; Makokha, EP; Mpoke, S; Orago, AA; Songok, EM; Tukei, PM; Vulule, JM | 1 |
Carr, A; Cooper, DA; Cunningham, PH; Duncombe, C; Grey, PA; Hecht, FM; Kahn, JO; Kaufmann, GR; Petersen, A; Quan, DC; Smith, DE; Zaunders, JJ | 1 |
Everall, IP; Foster, R; Olajide, D | 1 |
Cave, C; Kumar, A; St John, AM | 1 |
Bruun, JN; Garmark, VC; Holmedal, SH; Lindemann, R; Løkvik, BH; Rønsen, TK | 1 |
Blanche, S; Guihenneuc-Jouyaux, C; Le Chenadec, J; Mayaux, MJ | 1 |
Alimenti, A; Burdge, DR; Forbes, JC; Money, DM; Ogilvie, GS | 1 |
Broadhead, RL; Fiscus, S; Gibbons, A; Hoover, DR; Kumwenda, NI; Lema, V; Liomba, G; Miotti, PG; Nkhoma, C; Taha, TE | 1 |
Bouhour, D; Dumouchel-Champagne, H; Durupt, F; Ferry, T; Granier, P | 1 |
Chaisilwattana, P; Laothong, K; Sirimai, K; Sutchritpongsa, P | 1 |
Ahr, A; Bremerich, DH; Büchner, S; Faul-Burbes, C; Hingott, H; Kaufmann, M; Kessler, P | 1 |
Needham, DM | 1 |
do Lago, RF; Harrison, LH; Mendelsohn, AB; Moreira, RI; Moulton, LH; Schechter, M | 1 |
Mayss, A | 1 |
Chalermchockcharoenkit, A; Pongprasobchai, S; Roongpisuthipong, A; Sirimai, K | 1 |
Barberá, MJ; Barceló, JJ; Ferrer, E; Gallart, T; García, A; García, F; Gatell, JM; Lacarcel, M; Maleno, MJ; Martínez, C; Miró, JM; Plana, M; Podzamczer, D | 1 |
Beliaeva, VV; Bogoslovskaia, EV; Kravchenko, AV; Miroshnichenko, AV; Serebrovskaia, LV; Sitdykova, IuR | 1 |
Garweg, JG; Koerner, UB; Sarra, GM; Schulz, D | 1 |
Asavapiriyanont, S; Chalermchokcharoenkit, A; Chotpitayasunondh, T; Culnane, M; Jetsawang, B; Mock, PA; Neeyapun, K; Simonds, RJ; Skunodum, N; Tappero, J; Teeraratkul, A; Vanprapa, N | 1 |
Alexander, G; Christie, CD; Figueroa, JP; Harvey, KM; Johnson, N; McDonald, D; Mullings, AA; Palmer, P; Smikle, MF; Whorms, S; Williams, E | 1 |
Farthing, C; Guyer, B; Khanlou, H | 1 |
Post, MJ | 1 |
Ball, W; Barret, B; Blanche, S; Brunelle, F; Lachassine, E; Mayaux, MJ; Pautard, B; Raybaud, C; Tardieu, M | 1 |
Diaby, KL; Ekpini, ER; Kouassims, MK; Lin, LS; Matia, DM; Painter, TM; Roels, TH; Sibailly, TS; Wiktor, SZ | 1 |
Halem, SC | 1 |
Riley, LE; Yawetz, S | 1 |
Commenges, D; Hsu, CH; Murray, S; Taylor, JM | 1 |
Eilers, E; Feiterna-Sperling, C; Obladen, M; Schmitz, T; Weizsaecker, K | 1 |
Chambon, JF; Coulibaly, M; Ekpini, R; Malkin, JE; Msellati, P; Noba, V; Rey, JL | 1 |
Gładysz, A; Knysz, B; Rzeszutko, M; Zalewska, M | 1 |
Baldeweg, T; Catalan, J; Chinn, RJ; Chong, WK; Hall-Craggs, MA; Harrison, MJ; Kendall, BE; Paley, M; Pugh, K; Riccio, M; Weller, IV; Wilkinson, ID; Williams, IG | 1 |
Ahlenstiel, G; Altfeld, M; Kaufmann, DE; Kupfer, B; Lichterfeld, M; Mui, SK; Rockstroh, JK; Spengler, U; Vogel, M; Voigt, E; Walker, B | 1 |
Hirsch, HH; Mossdorf, E | 1 |
Aberg, J; Aweeka, FT; Bardeguez, A; Coombs, RW; Lizak, P; Rosenkranz, SL; Segal, Y; Thevanayagam, L; Watts, DH | 1 |
Bain, BJ; Benzie, A; Phelan, L; Wilkinson, MJ | 1 |
Giry, C; Hebert, JC; Lartigau-Roussin, C; Malvy, D; Pettinelli, ME; Receveur, MC | 1 |
Bowles, NE; Carabello, B; DeFreitas, G; Jimenez, S; Kearney, DL; Nelson, DP; Purevjav, E; Sanchez, XV; Shearer, WT; Taylor, MD; Towbin, JA; Varela, JJ; Vatta, M | 1 |
Eron, JJ; Fiscus, SA; Foust, E; Kuruc, J; Leone, PA; McCoy, SI; Patterson, KB; Pilcher, CD; Williams, D; Wolf, L | 1 |
Kukla, R | 1 |
Cauda, R; Donelli, G; Landay, AL; Lucia, MB; Malorni, W; Ortona, L | 1 |
Gohchi, K; Gotoh, M; Kinoshita, T; Matsuda, J; Saitoh, N; Tsukamoto, M | 1 |
Evans, JA; Levin, M; Marriage, SC; Walters, MD | 1 |
Flynn, PM; Fridland, A; McDonald, C; Robbins, BL; Rodman, J; Srinivas, RV | 1 |
Angarano, G; Appice, A; Fico, C; Giannelli, A; Monno, L; Pastore, G; Romanelli, C | 1 |
Arduino, JM; Bartlett, JA; Collier, AC; De Gruttola, V; Hirsch, MS; Jacobson, MA; Phair, JP; Reddy, M; Reichman, RC; Strickland, S | 1 |
Britton, S; Eriksson, S; He, Q; Jacobsson, B; Karlsson, A | 1 |
Berrebi, A; Claeyssens, S; Izopet, J; Rolland, M; Tricoire, J | 1 |
Burt, BA; Kleinman, DV; Swango, PA; Tomar, SL | 1 |
Calderón, EJ; Larder, B; Leal, M; Lissen, E; Luque, F; Medrano, FJ; Rey, C; Sánchez-Quijano, A; Torres, Y | 1 |
Frank, JW; Leblanc, M; Major, C; McLaughlin, J; O'Shaughnessy, MV; Read, SE; Strathdee, SA | 1 |
Catalan, J; Catt, S; Stygall, J | 1 |
Abrams, EJ; Bamji, M; Heagarty, M; Hernán, MA; Krasinski, K; Lambert, G; Matheson, PB; Rogers, MF; Thea, DM; Thomas, PA | 1 |
Haeffner-Cavaillon, N; Kazatchkine, MD; Sadeghi, HM; Weiss, L | 1 |
D'Silva, M; Flaherty, JP; Leibowitz, D | 1 |
Cameron, W; Gallicano, K; Garber, G; Pakuts, A; Sahai, J | 1 |
Cherin, P; Coutellier, A; Herson, S | 1 |
Aperia, K; Cox, S; Palmer, S; Wahren, B | 1 |
Ching, WT; Ho, DD; Mohri, H; Singh, MK | 1 |
Armstrong, FD; Seidel, JF; Swales, TP | 1 |
Andrieu, JM; Lu, W | 1 |
Besemer, D; Fong, SJ; Hoo, B; Irvine, B; Kern, DG; Pachl, C; Sheridan, PJ; Stempien, M; Todd, JA; Yeghiazarian, T | 1 |
Clotet, B; Gomez, M; Romeu, J; Ruiz, L; Sirera, G | 1 |
Borella, M; Cargnel, A; Clerici, F; Grassi, MP; Mangoni, A; Perin, C; Zocchetti, C | 1 |
Kania, RJ; McGarr, J; Molloy, PJ; Naum, SM; Van Thiel, DH | 1 |
Fahey, JL; Graham, NM; Mellors, J; Park, LP; Phair, JP; Piantadosi, S; Saah, AJ | 1 |
Zaretsky, MD | 1 |
Blattner, WA; Carrington, MN; Goedert, JJ; Kroner, BL; Mann, DL; Wilson, SE | 1 |
Greenlaw, J; Spike, J | 1 |
Cao, Y; Chen, S; Hahn, BH; Ho, DD; Kokka, R; Lifson, JD; Piatak, M; Saag, MS; Todd, J; Urdea, M | 1 |
Frøland, SS; Karlsen, NR; Reinvang, I | 2 |
Batki, SL; Chesney, MA; Delucchi, KL; London, JA; Sorensen, JL; Wall, TL | 1 |
Sharma, PK; Tami, TA | 1 |
Bindels, PJ; Coutinho, RA; Krol, A; Miedema, F; Roos, M; van den Hoek, JA; Veenstra, J | 1 |
Feussner, JR; Wong, JG | 1 |
Barker, GM; Holland, C; Katz, JA | 1 |
Alvaro, LC; Cortina, C; Fernandez, JM; Sadaba, F; Villaverde, FJ | 1 |
Chiodi, F; Fuchs, D; Gisslén, M; Hagberg, L; Norkrans, G; Svennerholm, B; Wachter, H | 1 |
Anderson, R; Davis, G; Drew, WL; Lalezari, J; Lang, W; Miner, RC | 1 |
Fahy-Chandon, B; Licht, E; Singer, EJ; Singer, P; Stoner, GL; Tomiyasu, U; Tourtellotte, WW | 1 |
Blaschke, TF; Sale, M; Sheiner, LB; Volberding, P | 1 |
Gerstoft, J; Gøtzsche, PC; Nielsen, C; Nielsen, CM; Vestergaard, BF | 1 |
Bubp, J; Israelski, D; Katzenstein, DA; Merigan, TC; Winger, E; Winters, M | 1 |
Bratt, G; Broliden, PA; Eriksson, L; Gilljam, G; Hinkula, J; Levén, B; Nordlund, S; Persson, C; Volvovitz, F; Wahren, B | 1 |
Bagnarelli, P; Clementi, M; Manzin, A; Menzo, S; Scalise, G; Valenza, A; Varaldo, PE | 1 |
Conant, M; Crane, MM; Duvic, M; Lehrman, SN; Mahoney, SE; Reveille, JD | 1 |
Brettler, D | 1 |
Chou, CC; Detels, R; Giorgi, JV; Gudeman, V; Isacescu, V; Mitsuyasu, RT; O'Rourke, S; Williams, GJ | 1 |
Bofill, M; Elford, J; Janossy, G; Lee, CA; Phillips, AN; Sabin, CA | 1 |
Mathé, G | 1 |
Bareggi, SR; Cinque, P; D'Arminio, A; Lazzarin, A; Mazzei, M; Nicolin, A; Pirola, R; Ruggieri, A | 1 |
Calderón, EJ; Leal, M; Lissen, E; Medrano, FJ; Rey, C; Torres, Y | 1 |
Craib, KJ; Hogg, RS; Montaner, JS; O'Shaughnessy, MV; Schechter, MT; Strathdee, SA | 1 |
Ganser, A; Geissler, RG; Guba, P; Gute, P; Helm, EB; Hoelzer, D; Morawetz, A; Ottmann, OG | 1 |
Kirton, CA | 1 |
Dyer, O | 1 |
Fonseca, VA; Martin, RE; Munshi, MN | 1 |
Beekmann, SE; Henderson, DK | 1 |
Arendt, G; Freund, HJ; Hefter, H; Hilperath, F; Strohmeyer, G; von Giesen, HJ | 1 |
Flexner, C; Hendrix, CW; Kuwahara, S; Lietman, PS; Pennypacker, S; Szebeni, J; Weinstein, JN | 1 |
Bassett, R; Cotton, DJ; Fischl, MA; Fogelman, I; Lim, L; Stanley, K; Volberding, P | 1 |
Ehrhardt, AA; Goetz, RR; Gorman, JM; Mayeux, R; Rabkin, J; Stern, Y; Williams, JB | 1 |
Duesberg, P | 2 |
Church, D; De Boer Visser, N; Gill, MJ; Macnab, KA; Sutherland, LR | 1 |
Gazzard, BG | 1 |
Green, G | 1 |
Winceslaus, J | 1 |
Durand, D; Grant, I; Gulevich, SJ; Heyes, MP; Kirson, D; McCutchan, JA; Mehta, P; Thal, LJ; Wallace, M | 1 |
Boubon, MC; Delfraissy, JF; Horovitz, J; Pons, JC; Taburet, AM; Wirtgen, P | 1 |
Coutinho, RA; Koot, M; Lange, JM; Miedema, F; Mulder, JW; Roos, MT; Schellekens, PT; Tersmette, M | 1 |
Byers, RH; Holmberg, SD | 1 |
Boucher, CA; Kellam, P; Lange, JM; Larder, BA; Schipper, P; Tijnagel, J; van Leeuwen, R | 1 |
Coombs, R; Gupta, P; Iversen, AK; Katzenstein, DA; Kozal, MJ; Meyer, WA; Ragni, MV; Rasheed, S; Shafer, RW; Winters, MA | 1 |
Málaga Guerrero, S; Santos Rodríguez, F | 1 |
Abbott, AF; Anderson, DJ; Mayer, KH; Politch, JA | 1 |
Arduino, JM; Chung, R; Crumpacker, CS; Hammer, SM; Japour, AJ; Lane, J; Mayers, DL; McLeod, GX; Reichman, R; Wagner, KF | 1 |
Dourakis, S; Goldin, RD; Lindley, R; Parkin, J; Wilkins, M | 1 |
Benhamou, JP; Boyer, N; Colin, JF; Erlinger, S; Lefort, V; Marcellin, P; Martinot-Peignoux, M; Matheron, S | 1 |
Buchbinder, SP; Bush, TJ; Conley, LJ; Hershow, RC; Holmberg, SD; Judson, FN; Katz, MH; Penley, KA | 1 |
Bálint Gábor, S | 1 |
Cooper, DA; Sindhusake, D; Stewart, GJ; Yeung, SC | 1 |
Chi, S; Fahy-Chandon, B; Singer, EJ; Syndulko, K; Tourtellotte, WW; Zorilla, C | 1 |
Courpotin, C; Lasfargues, G | 1 |
Dyer, C | 1 |
Hamed, KA; Holodniy, M; Katzenstein, DA; Merigan, TC; Winters, MA | 1 |
Baker, CJ; Bremer, JW; Dimitrov, DH; Doyle, M; Hollinger, FB; Kline, MW; Shearer, WT | 1 |
Amenta, PS; Bharucha, N; Cappell, MS; Dadhania, J; Gaur, S; Lupski, D; Mascarhenas, M; Rosenthal, S | 1 |
Clarke, JR; Mitchell, DM; Williamson, JD | 1 |
Bell, N; Dennis, S; Luke, DR; Sarnoski, TP | 1 |
Freiman, JP; Hamrell, MR; Helfert, KE; Stein, DS | 1 |
Balfour, HH; Erice, A; Irvin, JD; Kuebelbeck, V; Leske, VL; Myers, DE; Sannerud, KJ; Uckun, FM | 1 |
Davey, RT; Dewar, RL; Falloon, J; Haneiwich, SE; Kovacs, JA; Masur, H; Polis, MA; Reed, GF; Vasudevachari, MB; Walker, RE | 1 |
Boucher, CA; Cornelissen, M; Coutinho, RA; Goudsmit, J; Schuitemaker, H; Schuurman, R; van't Wout, AB; Veenstra, J | 1 |
Baldeweg, T; Burgess, A; Catalan, J; Catt, S; Gruzelier, J; Hawkins, D; Irving, G; Riccio, M; Stygall, J | 1 |
Aloisi, MS; D'Ubaldo, C; De Santis, MT; Girardi, E; Ippolito, G; Puro, V; Romano, S | 1 |
Bofill, M; Lee, CA; Lilley, P; Pasi, KJ; Phillips, AN; Sabin, CA | 1 |
Lee, CA; Phillips, AN; Sabin, CA | 1 |
Boyer, PJ; Bryson, YJ; Deveikis, A; Dickover, RE; Garratty, EM; Herman, SA; Keller, M; Plaeger, S; Sim, MS; Stiehm, ER | 1 |
Katzenstein, DA; Kundu, SK; Merigan, TC; Ramachandran, R; Winters, MA | 1 |
Gore, SM; Mcneil, AJ | 1 |
Ecker, JL | 1 |
Detels, R; Graham, NM; Hoover, DR; Mellors, JW; Park, LP; Phair, JP; Saah, AJ; Stein, DS | 1 |
Atkinson, JH; Butters, N; Chandler, JL; Delis, DC; Heindel, WC; Peavy, G; Ryan, L; Salmon, DP; Stout, JC; Taylor, M | 1 |
Boucher, CA; de Boer, RJ; de Jong, MD; Lange, JM; Schuurman, R; Stilianakis, NI; Veenstra, J | 1 |
Cooper, DA; Harrigan, PR; Kinghorn, I; Lange, JM; Larder, BA; Lavelle, J; Lefkowitz, L; McKinnis, R; Moore, M; Mulder, JW; Pennington, KN; Ramirez-Ronda, C; Rooney, JF; Schooley, RT; St Clair, M; Steel, H | 1 |
Mauskopf, JA; Paul, JE; Tilson, HH; White, AD; Wichman, DS | 1 |
Blaschke, T; Campbell, TB; Collier, A; Kahn, J; Kuritzkes, DR; Messari, F; Phair, J; Pottage, JC; Rosandich, ME; Schooley, RT; Stein, DS | 1 |
Arredondo-Garcia, JL; Flores-Rivera, E; Gorbea-Robles, MC; Paredes-Vivas, Y; Villegas-Castrejon, H | 1 |
Freeman, RC; French, JF; Rodriguez, GM | 1 |
Bloor, S; Harrigan, PR; Kemp, SD; Kinghorn, I; Kohli, A; Larder, BA; Nájera, I | 1 |
Bloor, S; Harrigan, PR; Kemp, SD; Kohli, A; Lange, JM; Larder, BA; Pennington, KN; Schooley, RT; St Clair, MH | 1 |
Brant, R; Gill, MJ; Macnab, KA; Murphy, A; Sutherland, LR | 1 |
Bird, AG; Brettle, RP; Burns, S; Gore, SM; Leen, CS; MacCallum, L; McNeil, AJ; Richardson, AM; Yap, PL | 1 |
Brettle, RP; Chiswick, A; Egan, V; Goodwin, GM; Pretsell, DO | 1 |
Gambertoglio, JG; Lalezari, JP; Peter, K | 1 |
Derancourt, C; Drobacheff, C; El M'Rini, T; Laurent, R; Leroy, J | 1 |
Heathcote, EJ; Mai, AL; O'Rourke, K; Yim, C | 1 |
Affrime, M; al-Uzri, A; Aweeka, FT; Cutler, DL; Dett, C; Franco, J; Guerciolini, R; Kahn, J; Mak, M; Peter, K | 1 |
Cosín, J; Fernández-Cruz, E; Montes, MG; Muñoz-Fernández, MA; Navarro, J; Zabay, JM | 1 |
Berger, JR; Pall, L; Stein, N | 1 |
Albrecht, H; Fenner, T; Greten, H; Lichtenberg, G; Stellbrink, HJ; Thiele, HG; van Lunzen, J; Zöller, B | 1 |
Finelli, E; Perrella, A; Perrella, O; Scalera, G; Scognamiglio, P; Tartaglia, G | 1 |
Antinori, A; Camilli, G; Murri, R; Patriarca, G; Zannoni, G | 1 |
Davison, FD; Scaravilli, F; Sweeney, BJ | 1 |
Aggarwal, S; Andreana, A; Gollapudi, S; Gupta, S; Tsuruo, T; Wien, D | 1 |
Fuchs, D; Gisslén, M; Hagberg, L; Larsson, M; Norkrans, G; Wachter, H | 1 |
Erridge, PL | 1 |
Barnes, L; Darby, C; Fogarty, J; Mulcahy, F; Murphy, GM; O'Connor, WJ; O'Moore, R | 1 |
Affrime, M; al-Uzri, A; Aweeka, FT; Cutler, D; Gambertoglio, JG; Kahn, J; Kwong, M; Mak, M | 1 |
Bechtel, LM; Starich, GH; Whitfield, RM | 1 |
Mito, RS; Wahlers, M | 1 |
Markowitz, JC; Spinelli, MG; Swartz, HA | 1 |
Barreiro Casal, G; Bernal Zamora, A; Cilleruelo Ortega, MJ; García López, M; Martín Fontelos, P; Mellado Peña, MJ; Pérez Jurado, ML; Villota Arrieta, J | 1 |
Alliegro, MB; Dorrucci, M; Pezzotti, P; Phillips, AN; Rezza, G | 1 |
Darby, G; France, AJ; Leigh Brown, AJ; McMenamin, J; Quigg, M; Rebus, S | 1 |
Baldeweg, T; Carter, S; Catalan, J; Chinn, RJ; Hall-Craggs, MA; Harrison, MJ; Kendall, BE; Miller, RF; Miszkiel, KA; Newman, SP; Paley, MN; Wilkinson, ID; Williams, IG | 1 |
Boix, V; Esteban, A; González, M; Mora, A; Pérez-Mateo, M; Portilla, J | 1 |
Eisen, JA; Katzenstein, DA; Merigan, TC; Shafer, RW | 1 |
De Gruttola, V; Fleming, TR; Lin, DY | 1 |
Bernard, P; Cony-Makhoul, P; Leng, B; Mahon, FX; Nabera, CB; Pellegrin, JL; Reiffers, J | 1 |
Clavel, F; Dupont, B; Fournier, S; Moulignier, A; Pialoux, G; Poveda, JD | 1 |
Confort-Gouny, S; Cozzone, PJ; Lamoureux, S; Nicoli, F; Salvan, AM; Vion-Dury, J | 1 |
Bitetto, C; Larocca, A; Leone, E; Maggi, P; Marcuccio, L; Monno, R; Quarto, M; Valenza, MA | 1 |
Brede, HD; Dietrich, U; Gehring, S; Husak, R; Jäger, H; Knechten, H; Knickmann, M; Orfanos, CE; Rübsamen-Waigmann, H; Ruppach, H; von Briesen, H; Wolf, E | 1 |
Abiteboul, D; Bell, DM; Cardo, DM; Ciesielski, CA; Culver, DH; Heptonstall, J; Ippolito, G; Lot, F; Marcus, R; McKibben, PS; Srivastava, PU | 1 |
Berrebi, A; Blanche, S; Bongain, A; Ciraru-Vigneron, N; Delfraissy, JF; Gallais, H; Mandelbrot, L; Matheron, S; Mayaux, MJ; Parnet-Mathieu, F; Rouzioux, C; Teglas, JP | 1 |
Bánhegyi, D; Czeizel, E | 1 |
Bagnarelli, P; Butini, L; Montroni, M; Munoz, C; Silvestri, G | 1 |
Gómez-Cano, M; Soriano, V | 1 |
Friedberg, DN; Heinemann, MH; Holland, GN; Rosberger, DF | 1 |
Bethel, J; Landay, AL; Schnittman, S | 1 |
Brun-Vézinet, F; De Loes, SK; Descamps, D; Hirschel, B; Perrin, L; Rakik, A; Yerly, S | 1 |
Aiuti, F; D'Offizi, G; Giovannetti, A; Mollicone, B; Oliva, A; Pandolfi, F; Pierdominici, M; Ricci, G | 1 |
Koopmans, PP; ter Hofstede, HJ; van Haelst, UJ | 1 |
Biollaz, J; Buchwalder, PA; Chesaux, JJ; Micheli, JL; Scalfaro, P | 1 |
Borzuchowska, A; Chlabicz, S; Rogowska-Szadkowska, D; Wiercińska-Drapało, A | 1 |
Bai, J; Daar, ES; Giorgi, JV; Hausner, MA; Majchrowicz, M; Tamaddon, M | 1 |
Diggle, PJ; Verbyla, AP | 1 |
Chang, I; González, RG; Guimaraes, AR; Hamberg, LM; Hunter, G; Navia, BA; Tracey, I | 1 |
Contopoulos-Ioannidis, DG; Ioannidis, JP | 1 |
Arienti, D; Clerici, M; Leal, M; Lissen, E; Medrano, FJ; Rey, C; Sanchez-Quijano, A; Torres, Y; Zagliani, A | 1 |
Alchediak, T; Christensen, LA; Morehouse, CR; Powell, TW; Silio, M | 1 |
Kam, KM; Kwok, MY; Lee, SS; Leung, WL; Li, PC; Wong, KH | 1 |
Collazos, J; Martínez, E; Mayo, J | 1 |
Kempf-Durepaire, G; Krantz, V; Lang, JM; Nicolle, M; Partisani, M; Rey, D; Schmitt, AC; Schmitt, MP | 1 |
Gaday, I; Senegas, F; Sleth, JC | 1 |
Mittlböck, M; Whitehead, J | 1 |
Baron, F; Daniel, C; Moutschen, M | 1 |
Costa, SJ; Jorden, V; Paul, SM; Ziskin, LZ | 1 |
Collantes, C; Guerrero, J; Russo, F | 1 |
Funke, AM | 1 |
Berkane, M; Bijleveld, CC; van de Water, HP; Wiggers, CC | 1 |
Aguilar, SM; Hardy, AM | 1 |
Cohen, P; Gayraud, M; Gherardi, R; Guillevin, L; Jarrousse, B; Leon, A; Lhote, F | 1 |
De Graeve, D; Lescrauwaet, B; Nonneman, W | 1 |
Gürtler, L | 1 |
Chazan, B; Firlag-Burkacka, E; Horban, A; Niemiec, KT | 1 |
Matchaba, P | 1 |
Adimora, AA; Fiscus, SA; Johnson, VA; Kenny, J; Lim, W; McKinney, R; Rupar, D; Schoenbach, VJ; Wilfert, C; Woods, C | 1 |
Karchmer, S; Mayón González, J; Paredes Vivas, Y; Villegas Castrejón, H | 1 |
Bellón, JM; Gurbindo, MD; Jiménez, JL; León, JA; Muñoz-Fernández, MA; Navarro, J; Resino, S | 1 |
Berro, O; Brindeiro, R; Caride, E; Correa, L; Oravec, RM; Stuyver, L; Tanuri, A; Vanderborght, B | 1 |
Fine, N; Hurwitz, JJ; Rachlis, AR | 1 |
Gray, G; IJsselmuiden, C; Lurie, M; Lurie, P | 1 |
Kessler, CM; Racoosin, JA | 1 |
Albert, J; Bratt, G; Eriksson, LE; Gilljam, G; Hinkula, J; Redfield, R; Sandström, E; Wahren, B | 1 |
Bloch, M; Carr, A; Cunningham, P; Smith, D; Vasak, E | 1 |
Chapman, S; Clendeninn, NJ; Powderly, WG; Quart, B; Saag, MS; Yu, G | 1 |
Aweeka, F; Hayashi, S; Jayesekera, D; Jayewardene, A; Shah, A; Thevanayagam, L | 1 |
Beltrami, JF; Cardo, DM; Jochimsen, EM; Luo, CC; Respess, RA; Schable, CA | 1 |
Duro, G; García, C; Hernández-Burruezo, JJ; Martín-Rubio, A; Omar, M; Romero, MD | 1 |
Cockram, A; Ellen, S; Judd, FK; Lyketsos, CG; Mijch, AM | 1 |
Bentwich, Z; Berrebi, A; Klepfish, A; Schattner, A; Shtalrid, M; Shvidel, L | 1 |
Ballmer, PE; Furrer, J; Müri, RM; Von Overbeck, J | 1 |
Brigido, LF; Casseb, JR; Duarte, AJ; Fonseca, LA; Reingold, AL | 1 |
Angel, JB; Badley, AD; Cameron, DW; Cassol, S; Chambers, KA; Gallicano, K; Hawley-Foss, N; Kravcik, S; Mandy, F; Parato, K; Phenix, BN | 1 |
Boag, F; Easterbrook, PJ; Gazzard, B; Goetghebeur, E; McLean, K; Yu, LM | 1 |
Clewley, G; Devereux, HL; Emery, VC; Griffiths, PD; Lee, CA; Loveday, C; Phillips, AN; Sabin, CA | 1 |
King, P; Masland, T | 1 |
Bethel, J; Fowler, MG; Lambert, JS; Read, J; Stiehm, ER; Watts, DH; Whitehouse, J | 1 |
de Souza, RS; Gómez-Marín, O; Guasti, S; Mitchell, CD; O'Sullivan, MJ; Oliveira, RH; Scott, GB | 1 |
Kennedy, I; Williams, S | 1 |
Badia, X; Benavides, A; Coma, A; López Lavid, C; Pinto, JL | 1 |
La Seta Catamancio, S; Parker, D; Rusconi, S; Sheridan, F | 1 |
Baker, R; Chougnet, CA; Khoury, MM; Kovacs, AA; Olivero, OA; Poirier, MC; Shearer, GM; Stek, AM | 1 |
Back, DJ; Carey, P; Hart, CA; Hoggard, PG; Khoo, SH; Lloyd, J; Maher, BA; Phiboonbanakit, D; Sales, SD; Wilkins, E | 1 |
Clotet, B; Del Romero, J; Leal, M; Pérez-Olmeda, M; Rodríguez, C; Rubio, A; Ruiz, L; Soriano, V | 1 |
Anastos, K; Augenbraun, M; Berhane, K; Cohen, M; Gange, SJ; Levine, AM; Masri-Lavine, L; Newman, M; Sanchez, M; Watts, H; Young, M | 1 |
Arendt, G; Hefter, H; Theisen, A; von Giesen, HJ | 1 |
Briones, C; del Romero, J; Hertogs, K; Pérez-Olmeda, M; Rodríguez, C; Soriano, V | 1 |
Calvillo, GM; George, L; Hinkin, CH; Llorente, AM; Marcotte, TD; Satz, P; Stern, MJ; van Gorp, WG | 1 |
Lo, B; Sengupta, S; Wolf, L | 1 |
Fujiyama, Y; Genga, I; Ichimura, H; Kageyama, S; Kakimoto, K; Kobayashi, N; Makokha, E; Okello, C; Songok, EM | 1 |
Harris, R; Kellagher, A; Moyle, GJ; Walker, M; Warburg, M | 1 |
Angarano, G; Galai, N; Graham, NM; Pezzotti, P; Rezza, G; Viale, P; Vlahov, D | 1 |
Arnó, A; Balaguer, M; Camafort, M; Cervantes, M; Clotet, B; Colomer, J; Gutiérrez, C; Ibáñez, A; Peraire, J; Richart, C; Ruiz, L; Vidal, F; Villalonga, C | 1 |
Antunes, F; Bouza, E; Harris, R; Moyle, GJ; Smith, D; Walker, M; Warburg, M | 1 |
Jamieson, D; Lindsay, M; Rodriguez, EJ; Spann, C | 1 |
Johnson, S | 1 |
Jackson, JB | 1 |
Amaro, J; Bienvenu, L; Burel, F; Hofman, P; Hofman, V; Itchaï, C | 1 |
Clark, DR; Dreves, AM; Ersbøll, AK; Jeppesen, DL; Kolte, L; Nielsen, JO; Nielsen, SD; Ryder, LP; Sørensen, TU; Valerius, NH | 1 |
Chaithongwongwatthana, S; Chantheptaewan, N; Chulasugondha, P; Hanwanich, M; Hawanon, P; Kongsin, P; Limpongsanurak, S; Phanuphak, P; Ruxrungtham, K; Tarounotai, U; Thaithumyanon, P; Thisyakorn, U; Triratwerapong, T; Ubolyam, S; Virutamasen, P | 1 |
Antinori, A; Bruno, R; Bugarini, R; Chigiotti, S; Chirianni, A; De Luca, A; De Stefano, C; Gritti, F; Monforte, Ade A; Moroni, M; Mussini, C; Perrella, O; Pezzotti, P; Piazza, M; Pizzigallo, E; Tirelli, U; Vigevani, GM | 1 |
Josefson, D | 1 |
Altman, LK | 2 |
Navarro, M | 1 |
Kolata, G | 1 |
Angell, M; Germain, A; Kliger, CH; Martin, WG | 1 |
Angell, M; Bagenda, D; Musoke-Mudido, P; Okie, S | 1 |
French, HW | 1 |
Raspberry, W | 1 |
Stolberg, SG | 3 |
Leary, WE | 1 |
Russell, SM | 1 |
Murphy, D | 1 |
Hansen, RW; Ranelli, PL; Ried, LD | 1 |
van Dam, MN | 1 |
Campbell, D | 1 |
Finn, L | 1 |
Hellman, D | 1 |
Resnik, DB | 2 |
Lie, RK | 1 |
Schüklenk, U | 1 |
Thomas, J | 2 |
del Rio, C | 1 |
Terrizzi, L | 1 |
Post, LF | 1 |
Berkowitz, AK; Breitowitz, YA; Davidowitz-Farkas, Z; Fins, JJ; Grumet, Z; Kenigsberg, K; Reisner, AI | 1 |
Curnin, KJ | 1 |
McKenna, JJ | 1 |
Abbadessa, V; Andreoni, M; D'Ettorre, G; Dalle, NE; Gallo, I; Mancino, G; Narciso, P; Nicastri, E; Parisi, SG; Sarmati, L; Traina, C; Vullo, V | 1 |
Anastos, K; Burke, J; Cohen, MH; Cook, JA; Grey, D; Kirstein, L; Palacio, H; Richardson, J; Wilson, TE; Young, M | 1 |
Chaithongwongwatthana, S; Limpongsanurak, S; Phanuphak, P; Punnahitanon, S; Ruxrungtham, K; Thaithumyanon, P; Thisyakorn, U; Ubolyam, S; Virutamasen, P | 1 |
Andrews, L; Friedland, GH; Jatlow, P; Lane, B; McCance-Katz, EF; Mitchell, SM; Rainey, PM; Snidow, JW | 1 |
Mastroianni, AC | 1 |
McMillion, E | 1 |
Schechter, M | 1 |
Waldholz, M | 1 |
Delzant, G; Grange, A; Marinho, E; Saiag, P; Winter, C | 1 |
Molina, JM | 1 |
Carter, JE; Shuster, AR | 1 |
Carosi, G; Chiodera, A; Jannelli, J; Milini, P; Pizzoccolo, G | 1 |
Escarguel, C; Lafeuillade, A; Papierok, G; Pautrat, G; Pellegrino, P; Quilichini, R | 1 |
Bass, HZ; Fahey, JL; Fischl, MA; Hardy, WD; Mitsuyasu, RT; Richman, DD; Spector, SA; Taylor, JM; Wang, YX | 1 |
Grünewald, T; Habermehl, KO; Maxeiner, HG; Ruf, B | 1 |
Astemborski, J; Cohn, S; Margolick, JB; Muñoz, A; Nelson, KE; Solomon, L; Vlahov, D | 1 |
Anderson, DJ; Horsburgh, CR; Martinez, A; Mayer, KH; O'Brien, TR; Padian, N; Politch, JA; Seage, GR | 1 |
Cappello, N; D'Elia, R; Dallacasa, P; de Martino, M; Ferraris, G; Gabiano, C; Loy, A; Plebani, A; Tovo, PA; Zuccotti, GV | 1 |
Bloom, AL; Bowen, DJ; Dannatt, AH; Dasani, H; Goodwin, SJ; Peake, IR | 1 |
Bindman, AB; Chan, AK; Katz, MH; Keane, D | 1 |
Lane, HC | 1 |
Bofill, M; Elford, J; Janossy, G; Lee, CA; Phillips, AN; Sabin, C | 1 |
Brůcková, M; Füst, G; Lackovicová, M; Mayer, V; Schmidtmayerová, H; Stanková, M; Surový, I; Ujhelyi, E | 1 |
Efantis, J; Gloeb, DJ; Lai, S; O'Sullivan, MJ | 1 |
Booth, DK; Koch, MA; Lagakos, SW; Myers, MW; Pettinelli, C; Volberding, PA | 1 |
Chiodo, F; Costigliola, P; Ricchi, E; Tumietto, F | 1 |
Armengaud, M; Cartier, F; Costagliola, D; Guiguet, M; Mary, M; Micoud, M; Mouton, Y; Sobesky, G; Valleron, AJ | 1 |
Magallón Martínez, M; Ortega, F; Pinilla, J | 1 |
Gazzard, BG; Hawkins, DA; Nelson, MR; Shanson, DC | 1 |
Christensen, KC; Gerstoft, J; Håkansson, C; Karlsson, A; Norkrans, G; Pedersen, C; Pehrson, PO; Petersen, CS; Sandström, E; Thorsen, S | 1 |
Brandon, WR | 1 |
Ascher, DP; Fowler, A; Roberts, C | 1 |
Dawkins, RL; French, MA; Mallal, SA; Mallon, DF; Shearwood, W | 1 |
Aznar, JA; Dasí, MA; Lerma, MA; Lorenzo, JI; Molina, R; Monteagudo, E; Monzó, E; Senent, ML | 1 |
Bouvet, E | 1 |
Para, MF | 1 |
Johnson, AM; Keenlyside, R; Phillips, AN | 1 |
Bloodgood, KM; High, KA; Hooper, SR; Stern, RA; van der Horst, CM | 1 |
Allan, JD; Beltangady, M; Canetta, R; Cooley, TP; Dolin, R; Kelley, S; Lambert, J; Liebman, HA; Rozencweig, M; Schacter, LP | 1 |
Chirurgi, VA; Edelstein, HE; Jagust, WJ; Martin, EM; Robertson, LC; San Giovanni, D; Sorensen, DJ | 1 |
Holodniy, M; Katzenstein, DA; Merigan, TC; Winters, MA | 1 |
Deschamps, L; Ricketts, M | 1 |
Coodley, GO; Elliot, DL; Goldberg, L | 1 |
Bizollon, T; Escaich, S; Lamelin, JP; Lepot, D; Ritter, J; Rougier, P; Sepetjan, M; Trepo, C | 1 |
Fleming, J; Harris, JR; Mitchell, DM; Moss, FM; Pinching, AJ; Shaw, RJ; Veale, D | 1 |
Boulberhane, A; Hellman, KB; Pierce, PF; Shepherd, LP; Ved Brat, SS | 1 |
Ebrahim, GJ; Martin, SB; Perra, A | 1 |
Lessell, S; Newman, NJ | 1 |
Connolly, S; Durrance, P; Fell, M; Fowler, CJ; Harrison, MJ; Herns, MV; Kendall, BE; Manji, H; McAllister, RH; Newman, SP | 1 |
Seligmann, M | 1 |
Delamothe, T | 1 |
Asboe, D; Boag, FC; Daniels, D; Erskine, D | 1 |
Bennett, WM; Gilbert, DN; Kohlhepp, SJ; Kremer, D; Munar, MY; Stinnett, EA; Swan, SK; Young, EW | 1 |
Arendt, G; Buescher, L; Elsing, C; Freund, HJ; Hefter, H; Hilperath, F | 1 |
Greco, R; Lavack, L; Rovers, J | 1 |
Bijleveld, CC; van de Water, HP | 1 |
Miller, BJ; Ptachcinski, R; Ragni, MV; Whalen, R | 1 |
Ashman, T; Jacobsberg, L; Perry, S; Ryan, J | 1 |
Buimovici-Klein, E; Cooper, LZ; Grieco, MH; Lange, M; McKinley, GF; Mohan, V; Sonnabend, JA | 1 |
Agosti, J; Coombs, RW; Corey, L; Gilbert, MJ; Greenberg, PD; Loughran, TP; Lupton, SD; Overell, RW; Riddell, SR; Scheeler, S | 1 |
Burk, RD; Feingold, AR; Kelley, KF; Klein, RS; Munk, G; Schreiber, K; Vermund, SH | 1 |
Detels, R; Graham, NM; Jacobson, LP; Kuo, V; Phair, JP; Rinaldo, CR; Saah, AJ; Vermund, SH; Zeger, SL | 1 |
Arnaudo, E; Dalakas, M; DiMauro, S; Moraes, CT; Schon, EA; Shanske, S | 1 |
Lang, W; Moss, A; Osmond, D; Samuel, M; Schrager, L; Winkelstein, W | 1 |
Detels, R; Graham, NM; Ho, M; Park, LP; Phair, JP; Saah, AJ; Vermund, SH; Zeger, SL | 1 |
Holodniy, M; Israelski, DM; Katzenstein, DA; Merigan, TC | 1 |
Gazzard, B; Youle, M | 1 |
Bennett, JM; Cohen, P; Kahn, J; Kaplan, L; Levine, AM; Metroka, C; Rarick, MU; Rodman, N; Walsh, C; Wernz, JC | 1 |
Debouck, C; Goudsmit, J; Keet, R; Lange, JM; Osterhaus, AD; Schattenkerk, JK; Teeuwsen, VJ; van den Akker, R | 1 |
Cancio, MR; Hill, DA; Holt, DA; Sinnott, JT | 1 |
Clark, AG; Holodniy, M; Katzenstein, DA; Merigan, TC; Schwartz, DH | 1 |
Cameron, DW; Gallicano, KD; Garber, G; Kriger, F; McGilveray, IJ; Sahai, J; Tobe, S | 1 |
Callaham, ML | 1 |
Beall, G; Boyar, A | 1 |
Elford, J; Griffiths, P; Janossy, G; Kernoff, P; Lee, CA; Phillips, AN | 1 |
Buzón Rueda, L; Dorado, ML | 1 |
Amato, DA; Balsley, J; Benoit, S; Brettler, D; Brownstein, A; Kramer, AS; Merigan, TC; Perez-Michael, A; Power, M; Price, WA | 1 |
Deutsche, J; Goldsmith, JM; Green, D; Tang, M | 1 |
Bach, JF; Bary, M; Delabesse, E; Girot, R; Maier Redelsperger, N; Vittecoq, D | 1 |
Dalakas, M; Illa, I; Nath, A | 1 |
Wexner, SD | 1 |
Chaloupka, K; Collier, AC; Coombs, RW; Corey, L; Koehler, JK; Krieger, JN; Murphy, VL; Ross, SO | 1 |
Cooper, DA; Evans, L; Gaines, H; Imrie, A; Lindback, S; Strannegard, O; Tindall, B; Tsang, ML; von Sydow, MA | 1 |
Allen, UD; Detsky, AS; Guerriere, M; Read, SE | 1 |
Holechek, MJ | 1 |
O'Neill, JF; Paauw, DS | 1 |
Chaloupka, K; Collier, AC; Coombs, RW; Corey, L; Cummings, DK; Krieger, JN; Murphy, VL; Ross, SO | 1 |
Barton, SE; Kell, PD | 1 |
Barrett, D; Cumming, W; Davis, J; Kalen, V; Kao, KJ; Lian, E; Mehta, P; Reiter, W; Saba, H; Sandler, E | 1 |
Chiarotti, F; Ghirardini, A; Gringeri, A; Mannucci, PM; Schinaia, N | 1 |
Futterman, D; Hein, K | 1 |
Nicholas, SW | 1 |
Barnett, JH; Gilson, I | 1 |
Boone, EJ; Kovacs, JA; Lane, HC; Metcalf, JA; Quinnan, GV; Sawyer, LA; Zoon, KC | 1 |
Becker, Y | 1 |
Elsing, C; Franke, M; Höffken, G; Lode, H; Noack, H; Petri, M; Ruhnke, M; Schrappe-Bächer, M; Stellbrink, HJ; Weiss, R | 1 |
Anderson, D; Baron, D; Bystritsky, A; Levine, S | 1 |
Skutar, C | 1 |
Muntean, W; Zenz, W | 1 |
Jäger, H | 1 |
Bratzke, B; Orfanos, CE; Schaart, F; Stadler, R | 1 |
Iezza, A; Selwyn, PA | 1 |
Elmslie, K; Mulligan, L; Ricketts, M | 1 |
Gaub, J; Jakobsen, J; Smith, T; Trojaborg, W | 1 |
Gail, MH; Goedert, JJ; Rosenberg, PS | 1 |
Bender, AN; Farraye, J; Mendelson, SG; Simpson, DM; Wolfe, DE | 1 |
Alegre, VA; Aliaga, A; Febrer, MI; Grau-Massanes, M; Millan, F; Navarro, V; Pujol, C; Salavert, M | 1 |
Dobloug, JH | 1 |
Covino, JM; McCormack, WM | 1 |
Bird, AG; Matthes, J; Walker, LA; Watson, JG | 1 |
Goldman, E; Lee, CA; Miller, R | 1 |
Broder, S; Ghrayeb, J; Krohn, K; Lähdevirta, J; Mattinen, S; Ranki, A; Yarchoan, R | 1 |
Breuer, J; Jeffries, DJ | 1 |
Bergstresser, PR; Coldiron, BM | 1 |
Jones, WN | 1 |
Blanc, AP; Drony, S; Moriceau, M; Prajs, E; Routy, JP; Sarrazin, C; Viallet, F | 1 |
Craib, KJ; Elmslie, KD; Le, TN; McLeod, WA; Montaner, JS; O'Shaughnessy, MV; Schechter, MT; Willoughby, B | 1 |
Coutinho, RA; de Goede, RE; de Wolf, F; Eeftink-Schattenkerk, JK; Goudsmit, J; Huisman, JG; Lange, JM; Miedema, F; Schellekens, PT; Tersmette, M | 1 |
Blum, R; Hollander, H; Lifson, AR; Maha, M; Nusinoff-Lehrman, S; Rutherford, GW | 1 |
Benson, EM; Elliott, PJ; Kwiatek, RA | 1 |
Vesterdal, A | 2 |
Marcus, U | 2 |
Benda, H; Mannhalter, C; Panzer, S; Stain, C | 1 |
Coles, P | 1 |
Bonnevie, O; Buhl, M; Mathiesen, LR; Nielsen, C; Nielsen, L; Pedersen, C; Søeberg, B; Teglbjaerg, LL; Thorsen, B; Vestergaard, BF | 1 |
Goudsmit, J; Lange, JM | 1 |
Balachandran, R; Enrico, A; Gupta, P; Ho, M; Rinaldo, C | 1 |
Barnes, DC; Fuchs, E; Quinn, TC; Spivak, JL | 1 |
Perkins, RJ; Rodriguez, P; Sachdev, PS; Wright, JM | 1 |
Morse, GD; Olson, J; Plank, C; Portmore, A; Reichman, RC; Taylor, C | 1 |
Ballem, PJ; Belzberg, A; Buskard, N; Chambers, H; Devine, D; Doubroff, P; Mikulash, C; Sartori, C; Spurston, B | 1 |
Bauer, S | 1 |
Aukrust, P; Hestad, K | 1 |
Colaneri, S; Fillastre, JP; Pioger, JC; Singlas, E; Taburet, AM | 1 |
Clements, ML; Dallabetta, GA; Farzadegan, H; Margolick, J; Miotti, PG; Nelson, KE | 1 |
Carey, P; Coker, D; Evans, CC; Martin, J; O'Mahony, C; Timmins, D; Williams, C | 1 |
Bhalla, R; Chirmule, N; Good, RA; Harper, R; Leombruno, C; Lim, W; Nelson, RP; Pahwa, R; Pahwa, S | 1 |
Näthke, HE | 1 |
Bedello, PG; Depaoli, MA; Tamponi, M | 1 |
Chavanet, P; Diquet, B; Portier, H; Waldner, A | 1 |
Lindley, D | 1 |
Bryan, CS; Postic, B | 1 |
Dubois, D; Lacour, JP | 1 |
Ball, LM | 1 |
Bingham, J; Brettle, RP; Cowan, FM; Flegg, PJ; Gray, JA; Hargreave, D; Jones, G; MacCallum, LR; Welsby, PD; Whitelaw, J | 1 |
Bierling, P; Clauvel, JP; Ferchal, F; Oksenhendler, E; Seligmann, M | 1 |
Clements, ML; Cohn, S; Miotti, P; Nelson, KE; Polk, BF | 1 |
Batellier, L; Chaumeil, C; Fribourg Blanc, A; Frottier, J; Liotet, S; Meyohas, MC; Sainte Laudy, J | 1 |
Bartlett, JA | 1 |
Aronstam, A | 1 |
Wahn, V | 1 |
Glaser, V | 1 |
Mok, J | 1 |
Nielsen, JO | 1 |
Chevalier, A; Norol, F; Picard, C; Schaeffer, A; Sobel, A | 1 |
Kennedy, CJ; Paradise, M; Wu, AW | 1 |
32 review(s) available for zidovudine and AIDS Seroconversion
Article | Year |
---|---|
Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
Topics: Antiviral Agents; Coinfection; DNA, Viral; Emtricitabine; Female; Hepatitis B e Antigens; Hepatitis B virus; HIV; HIV Infections; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnant Women; Ritonavir; Tenofovir; Zidovudine | 2023 |
Non-occupational postexposure prophylaxis for HIV: a systematic review.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Databases, Bibliographic; Drug Combinations; Drug Therapy, Combination; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Lopinavir; Premedication; Pyrimidinones; Ritonavir; Substance Abuse, Intravenous; Time Factors; Treatment Outcome; Unsafe Sex; Zidovudine | 2009 |
[Pharmacokinetic interactions between methadone and antiretroviral medication in HIV positive patients].
Topics: Anti-HIV Agents; HIV Seropositivity; Humans; Methadone; Narcotics; Substance-Related Disorders; Zidovudine | 2002 |
Antiretroviral therapy-induced psychosis: case report and brief review of the literature.
Topics: Adult; Antipsychotic Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combinations; Female; Hallucinations; HIV Seropositivity; Humans; Lamivudine; Nevirapine; Psychoses, Substance-Induced; Zidovudine | 2003 |
Evolution of HIV-1-related conjunctival molluscum contagiosum under HAART: report of a bilaterally manifesting case and literature review.
Topics: Adult; Antiretroviral Therapy, Highly Active; Conjunctival Diseases; Drug Combinations; Eye Infections, Viral; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Molluscum Contagiosum; Zidovudine | 2004 |
Pediatric HIV infection: a neuropsychological and educational challenge.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Central Nervous System Diseases; Child; Child Behavior Disorders; Child, Preschool; Cognition Disorders; Developmental Disabilities; Female; HIV Seropositivity; Humans; Immunosuppression Therapy; Infant; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Zidovudine | 1993 |
AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter?
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; Cohort Studies; Double-Blind Method; Female; HIV Seropositivity; Humans; Immune System; Lymphocyte Count; Male; Zidovudine | 1995 |
AIDS: lessons from the last decade and prospects for the future.
Topics: Acquired Immunodeficiency Syndrome; Blood Transfusion; Clarithromycin; HIV Seropositivity; Humans; Mycobacterium Infections; Pneumocystis; Pneumonia; Sexual Behavior; Substance-Related Disorders; Trimethoprim; Zidovudine | 1995 |
Are HIV-1 seropositive subjects submitted to one of the innumerable AZT randomized double-blind trials, definitively victims of cross and/or common resistance to all virostatics, even in combinations?
Topics: Double-Blind Method; Drug Resistance; Drug Therapy, Combination; HIV Seropositivity; HIV-1; Humans; Randomized Controlled Trials as Topic; Zidovudine | 1994 |
Managing occupational risks in the dental office: HIV and the dental professional.
Topics: Blood-Borne Pathogens; Dental Staff; Didanosine; HIV Infections; HIV Seropositivity; Humans; Needlestick Injuries; Occupational Exposure; Risk Factors; Universal Precautions; Zidovudine | 1994 |
[Nephropathy associated with the human immunodeficiency virus in children].
Topics: AIDS-Associated Nephropathy; Child; Child, Preschool; HIV Seropositivity; Humans; Immunoglobulin A; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Kidney; Kidney Diseases; Kidney Transplantation; Steroids; Zidovudine | 1993 |
[Azidothymidine in the management of immune deficiency complex].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Dose-Response Relationship, Drug; Female; HIV Infections; HIV Seropositivity; Humans; Male; Prognosis; Zidovudine | 1993 |
[Human immunodeficiency type 1 virus (HIV-1) primary infection].
Topics: HIV Seropositivity; HIV-1; Humans; Prognosis; Skin Diseases; Zidovudine | 1995 |
[Principles of counseling and care of HIV-1 seropositive pregnant women in the light of a Hungarian case].
Topics: Adult; Counseling; Female; HIV Seropositivity; HIV-1; Humans; Hungary; Pedigree; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Zidovudine | 1997 |
[Resistance to antiretroviral drugs].
Topics: Antiviral Agents; Drug Resistance; Drug Resistance, Multiple; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nevirapine; Point Mutation; Retroviridae; Retroviridae Infections; Zidovudine | 1997 |
Maternal cell-free viremia in the natural history of perinatal HIV-1 transmission: a meta-analysis.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; ROC Curve; Viral Load; Viremia; Zidovudine | 1998 |
[Current position on the care of HIV-seropositive pregnancies].
Topics: Acquired Immunodeficiency Syndrome; Cesarean Section; Female; Germany; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
[Antiretroviral therapy in pregnant women with HIV].
Topics: Anti-HIV Agents; Female; HIV Seropositivity; Humans; Pregnancy; Pregnancy Complications; Zidovudine | 1998 |
[Response of fetal macrophages in the placenta of pregnant HIV-positive patients with and without antiretroviral treatment].
Topics: Antiviral Agents; Didanosine; Female; HIV Infections; HIV Seropositivity; Humans; Macrophages; Pregnancy; Pregnancy Complications, Infectious; Retroviridae; Zidovudine | 1999 |
Occupational exposure to HIV and post-exposure prophylaxis in healthcare workers.
Topics: Anti-HIV Agents; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Exposure; Reverse Transcriptase Inhibitors; United Kingdom; Zidovudine | 2000 |
Ethical issues in early detection of HIV infection to reduce vertical transmission.
Topics: Breast Feeding; Ethics; Female; Health Policy; HIV; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Informed Consent; Mandatory Testing; Pregnancy; Prenatal Care; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 2000 |
HIV vaccine evaluation center in Rio de Janeiro, Brazil.
Topics: Adolescent; Adult; AIDS Vaccines; Anti-HIV Agents; Behavior Therapy; Bisexuality; Brazil; Clinical Trials, Phase II as Topic; Disease Transmission, Infectious; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV Seropositivity; Homosexuality; Humans; Incidence; Lamivudine; Male; Middle Aged; Safety; Sensitivity and Specificity; Zidovudine | 2002 |
Current status of therapy for human immunodeficiency virus type 1.
Topics: CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Didanosine; Drug Resistance; HIV Infections; HIV Seropositivity; HIV-1; Humans; T-Lymphocytes, Helper-Inducer; Zalcitabine; Zidovudine | 1992 |
AIDS and hemophilia: experience in the La Paz Hemophilia Center.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Blood Coagulation Factors; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Drug Contamination; Hemophilia A; HIV Core Protein p24; HIV Infections; HIV Seropositivity; HIV-1; Humans; Incidence; Infant; Leukocyte Count; Middle Aged; Prognosis; Spain; Survival Analysis; Transfusion Reaction; Zidovudine | 1992 |
Reported seroconversions to human immunodeficiency virus among workers worldwide--a review.
Topics: Aged; Documentation; Female; Health Occupations; HIV Seropositivity; Humans; Needlestick Injuries; Occupational Diseases; Population Surveillance; Zidovudine | 1992 |
The treatment of HIV disease.
Topics: Antiviral Agents; CD4 Antigens; Counseling; Drug Evaluation; HIV Infections; HIV Seropositivity; Humans; Immunotherapy; Opportunistic Infections; Receptors, Virus; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Zidovudine | 1990 |
Human immunodeficiency virus and the primary care physician.
Topics: AIDS Serodiagnosis; CD4-Positive T-Lymphocytes; Counseling; HIV Seropositivity; Humans; Leukocyte Count; Physician-Patient Relations; Physicians, Family; Vaccination; Zidovudine | 1990 |
Rationale for anti-AIDS chemotherapy directed at HIV-1 infected dendritic cells in seropositive individuals prior to the appearance of ARC and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adrenal Cortex Hormones; AIDS-Related Complex; Combined Modality Therapy; Dendritic Cells; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Meta-Analysis as Topic; Tretinoin; Ultraviolet Therapy; Zidovudine | 1990 |
[Integrated management of the HIV positive patient--medical, psychological and psychosocial aspects].
Topics: Combined Modality Therapy; HIV Infections; HIV Seropositivity; Humans; Physician-Patient Relations; Sick Role; Social Adjustment; Zidovudine | 1990 |
Zidovudine in symptomless HIV infection.
Topics: AIDS-Related Complex; Clinical Trials as Topic; HIV Seropositivity; Humans; Multicenter Studies as Topic; Random Allocation; Time Factors; Zidovudine | 1989 |
Management of the HIV-infected patient.
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; HIV Seropositivity; Humans; Leukocyte Count; Zidovudine | 1988 |
[Management of a subject with HIV positive serology].
Topics: Acquired Immunodeficiency Syndrome; Blood Cell Count; CD4-Positive T-Lymphocytes; Follow-Up Studies; HIV Seropositivity; Humans; Opportunistic Infections; Prognosis; Skin Diseases; Zidovudine | 1988 |
89 trial(s) available for zidovudine and AIDS Seroconversion
Article | Year |
---|---|
Health outcomes of HIV-exposed uninfected African infants.
Topics: Anti-Retroviral Agents; Antiviral Agents; Breast Feeding; Cause of Death; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Morbidity; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Zidovudine | 2013 |
Efficacy and safety of tenofovir-containing antiretroviral therapy in women who acquired HIV while enrolled in tenofovir gel prophylaxis trials.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Emtricitabine; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Patient Safety; Pregnancy; Primary Prevention; RNA, Viral; South Africa; Tenofovir; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Viral Load; Zidovudine | 2017 |
Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Treatment Outcome; Zidovudine | 2008 |
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
Topics: Abortion, Spontaneous; Adenine; Adult; Anti-HIV Agents; Body Height; Body Weight; Breast Feeding; Burns; Cause of Death; Child, Preschool; Congenital Abnormalities; Drug Combinations; Female; Follow-Up Studies; Fractures, Bone; Growth; HIV Infections; HIV Seropositivity; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Measles; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Respiratory Tract Infections; Tenofovir; Uganda; Zidovudine; Zimbabwe | 2012 |
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Atrophy; CD4 Lymphocyte Count; DNA, Mitochondrial; Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Subcutaneous Fat; Treatment Outcome; Young Adult; Zidovudine | 2012 |
Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Nelfinavir; Prospective Studies; RNA, Viral; Viral Load; Zidovudine | 2003 |
Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
Topics: Anti-HIV Agents; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2003 |
[Anesthetic regimen for HIV positive parturients undergoing elective cesarean section].
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Anti-HIV Agents; Cesarean Section; Female; Hemodynamics; HIV Seropositivity; Humans; Infant, Newborn; Nerve Block; Pain, Postoperative; Postoperative Complications; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Zidovudine | 2003 |
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
Topics: Adult; Aged; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Lamivudine; Lymphocyte Activation; Male; Middle Aged; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Zidovudine | 2004 |
Evaluating programs to prevent mother-to-child HIV transmission in two large Bangkok hospitals, 1999-2001.
Topics: Anti-HIV Agents; Breast Feeding; Cross-Sectional Studies; Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; National Health Programs; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 2005 |
Efficacy of tenofovir as intensification of zidovudine/lamivudine/abacavir fixed-dose combination in the treatment of HIV-positive patients.
Topics: CD4 Lymphocyte Count; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Retrospective Studies; RNA, Viral; Viral Load; Zidovudine | 2005 |
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Reverse Transcriptase Inhibitors; RNA, Viral; Sex Factors; Viral Load; Zidovudine | 2006 |
The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antiviral Agents; Case-Control Studies; CD4 Lymphocyte Count; Double-Blind Method; Female; HIV Seropositivity; Humans; Male; Predictive Value of Tests; Treatment Outcome; Zidovudine | 1995 |
Emergence and clinical relevance of mutations associated with zidovudine resistance in asymptomatic HIV-1 infected patients.
Topics: Adult; Antiviral Agents; Base Sequence; CD4 Lymphocyte Count; Codon; Cohort Studies; Disease Progression; Double-Blind Method; Drug Resistance, Microbial; Female; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Male; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Zidovudine | 1995 |
Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.
Topics: Adult; Cross-Over Studies; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Seropositivity; Humans; Male; Metabolic Clearance Rate; Zidovudine | 1995 |
Lack of short-term efficacy of N-acetyl-L-cysteine in human immunodeficiency virus-positive patients with CD4 cell counts < 250/mm3.
Topics: Acetylcysteine; Administration, Oral; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Seropositivity; Humans; Male; Zidovudine | 1995 |
AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter?
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; Cohort Studies; Double-Blind Method; Female; HIV Seropositivity; Humans; Immune System; Lymphocyte Count; Male; Zidovudine | 1995 |
Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care.
Topics: Adult; CD4 Lymphocyte Count; Drug Monitoring; Female; Follow-Up Studies; HIV Seropositivity; Humans; Male; Methadone; Middle Aged; Nurse-Patient Relations; Patient Care Team; Patient Education as Topic; Pilot Projects; Substance Abuse, Intravenous; Treatment Refusal; Zidovudine | 1995 |
The effects of azidothymidine therapy on pseudocholinesterase concentrations in asymptomatic HIV-positive patients.
Topics: Adult; Butyrylcholinesterase; HIV Seropositivity; Humans; Male; Middle Aged; Pilot Projects; Zidovudine | 1994 |
Failure of high-dose oral acyclovir to suppress CMV viruria or induce ganciclovir-resistant CMV in HIV antibody positive patients.
Topics: Acyclovir; Administration, Oral; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Fibroblasts; Follow-Up Studies; Ganciclovir; HIV Seropositivity; Humans; Zidovudine | 1995 |
Zidovudine response relationships in early human immunodeficiency virus infection.
Topics: Bayes Theorem; CD4-Positive T-Lymphocytes; Dose-Response Relationship, Drug; HIV Seropositivity; Humans; Leukocyte Count; Models, Biological; Zidovudine | 1993 |
[Survival of patients with zidovudine resistant HIV].
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Cohort Studies; Double-Blind Method; Drug Resistance, Microbial; HIV Seropositivity; Humans; Leukocyte Count; Male; Prognosis; Zidovudine | 1994 |
Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160.
Topics: Adult; CD4-Positive T-Lymphocytes; Female; Follow-Up Studies; Gene Products, env; HIV; HIV Core Protein p24; HIV Envelope Protein gp120; HIV Envelope Protein gp160; HIV Seropositivity; Humans; Immunity, Cellular; Immunization; Immunization, Secondary; Leukocyte Count; Lymphocyte Activation; Male; Middle Aged; Peptide Fragments; Protein Precursors; Recombinant Proteins; Zidovudine | 1994 |
Zidovudine improves psoriasis in human immunodeficiency virus-positive males.
Topics: Adult; Body Surface Area; CD4-Positive T-Lymphocytes; Follow-Up Studies; HIV Seropositivity; Humans; Leukocyte Count; Male; Psoriasis; T-Lymphocytes, Cytotoxic; Zidovudine | 1994 |
Pharmacokinetics of zidovudine in HIV-positive patients with liver disease.
Topics: Adult; Half-Life; HIV Infections; HIV Seropositivity; Humans; Liver Diseases; Metabolic Clearance Rate; Zidovudine | 1994 |
Does early zidovudine treatment prevent the emergency of syncytium-inducing human immunodeficiency virus?
Topics: CD4-Positive T-Lymphocytes; Cross-Sectional Studies; Follow-Up Studies; Giant Cells; HIV Seropositivity; HIV-1; Humans; Placebos; Time Factors; Zidovudine | 1994 |
Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type I clinical trials. AIDS Clinical Trials Group (ACTG).
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Analgesics; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Clinical Protocols; Double-Blind Method; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Male; Nonprescription Drugs; Vitamins; Zidovudine | 1994 |
Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; Double-Blind Method; Genetic Variation; HIV Infections; HIV Seropositivity; HIV-1; Homosexuality; Humans; Male; Phenotype; Treatment Outcome; Zidovudine | 1993 |
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.
Topics: Amino Acids; Base Sequence; Cells, Cultured; Codon; Didanosine; DNA Primers; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Genes, pol; HIV Seropositivity; HIV-1; Humans; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Proviruses; RNA, Viral; Zidovudine | 1994 |
Progression of periodontal disease in HIV seropositive patients.
Topics: Adult; Case-Control Studies; CD4-CD8 Ratio; Cohort Studies; Concanavalin A; Dental Plaque Index; HIV Infections; HIV Seropositivity; Humans; Lymphocyte Activation; Lymphocytes; Male; Periodontal Index; Periodontitis; Phytohemagglutinins; Regression Analysis; Time Factors; Zidovudine | 1993 |
Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy.
Topics: Anti-Bacterial Agents; Cross-Sectional Studies; Didanosine; DNA, Viral; Drug Therapy, Combination; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; Longitudinal Studies; Male; RNA, Viral; Semen; T-Lymphocytes; Zidovudine | 1993 |
Influence of pentoxifylline on renal function in HIV-seropositive patients.
Topics: Adult; Analysis of Variance; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Kidney; Male; Middle Aged; Pentoxifylline; Prospective Studies; Time Factors; Urodynamics; Zidovudine | 1993 |
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Benzoxazoles; beta 2-Microglobulin; Biomarkers; CD4 Antigens; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; HIV Core Protein p24; HIV Seropositivity; HIV-1; Humans; Male; Neoplasms; Pyridones; Time Factors; Viremia; Zidovudine | 1993 |
Neurophysiological evaluation of zidovudine in asymptomatic HIV-1 infection: a longitudinal placebo-controlled study.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Evoked Potentials, Visual; HIV Infections; HIV Seropositivity; HIV-1; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Zidovudine | 1995 |
Polyethylene glycol-modified interleukin-2 and thymosin alpha 1 in human immunodeficiency virus type 1 infection.
Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Seropositivity; Humans; Interleukin-2; Lymphocyte Activation; Male; Polyethylene Glycols; RNA, Viral; Thymosin; Zidovudine | 1996 |
Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; HIV Seropositivity; Humans; Longitudinal Studies; Male; Proportional Hazards Models; Zalcitabine; Zidovudine | 1996 |
Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Phenotype; RNA, Viral; Zalcitabine; Zidovudine | 1996 |
Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team.
Topics: Adult; Antipyrine; Antiviral Agents; Base Sequence; Benzoxazoles; Cross-Over Studies; DNA Primers; DNA, Viral; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genes, pol; Genotype; HIV Seropositivity; HIV-1; Humans; Male; Molecular Sequence Data; Pilot Projects; Pyridones; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
[Comparative study of the placenta from HIV+ mothers. Ultrastructural analysis].
Topics: Antiviral Agents; Didanosine; Female; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Microscopy, Electron; Placenta; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1996 |
Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative Group.
Topics: Antigens, CD; Antiviral Agents; CD4 Antigens; Coculture Techniques; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HeLa Cells; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lymphocytes; Microbial Sensitivity Tests; Phenotype; Point Mutation; RNA-Directed DNA Polymerase; Zalcitabine; Zidovudine | 1996 |
Oral and intravenous zidovudine pharmacokinetics: the effect of granulocyte-macrophage colony stimulating factor.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Antiviral Agents; Cross-Over Studies; Drug Interactions; Glucuronates; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Seropositivity; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Zidovudine | 1995 |
Headache and human immunodeficiency virus infection: a case control study.
Topics: Adolescent; Adult; Brain Diseases; Case-Control Studies; CD4 Lymphocyte Count; Chi-Square Distribution; Female; Headache; HIV Seropositivity; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Prevalence; Prospective Studies; Risk Factors; Zidovudine | 1996 |
Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection: evidence for an only transient interruption by treatment.
Topics: Adult; Anti-HIV Agents; beta 2-Microglobulin; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Seropositivity; HIV-1; Humans; Kinetics; Male; RNA, Viral; Saquinavir; Viral Load; Zalcitabine; Zidovudine | 1996 |
Combined therapy with zidovudine, recombinant granulocyte colony stimulating factors and erythropoietin in asymptomatic HIV patients.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; HIV Seropositivity; Humans; Male; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor: the effects of zidovudine.
Topics: Adult; Antiviral Agents; Cross-Over Studies; Drug Interactions; Granulocyte Colony-Stimulating Factor; HIV Seropositivity; Humans; Middle Aged; Recombinant Proteins; Zidovudine | 1996 |
Abnormalities in the metabolism of acetaminophen in patients infected with the human immunodeficiency virus (HIV).
Topics: Acetaminophen; Acquired Immunodeficiency Syndrome; Adult; Analgesics, Non-Narcotic; Antiviral Agents; Female; HIV Seropositivity; Humans; Male; Reference Values; Zidovudine | 1997 |
Phenotypic variability of lymphocyte populations in peripheral blood and lymph nodes from HIV-infected individuals and the impact of antiretroviral therapy. DATRI 003 Study Group. Division of AIDS Treatment Research Initiative.
Topics: Anti-HIV Agents; B-Lymphocytes; Didanosine; HIV Seropositivity; Humans; Immunophenotyping; Lymph Nodes; Lymphocyte Count; Lymphocyte Subsets; Prospective Studies; T-Lymphocytes; Zidovudine | 1998 |
Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): effects of administration of Zidovudine in vivo and interleukin-2 in vitro.
Topics: Adult; Anti-HIV Agents; Apoptosis; Female; Follow-Up Studies; HIV Envelope Protein gp160; HIV Seropositivity; HIV-1; Humans; Interleukin-2; Lymphocyte Activation; Male; Middle Aged; Zidovudine | 1998 |
[Prophylaxis after occupational exposure to human immunodeficiency virus (HIV)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Female; Health Knowledge, Attitudes, Practice; Health Personnel; HIV; HIV Seropositivity; Humans; Male; Middle Aged; Needlestick Injuries; Occupational Diseases; Occupational Exposure; Risk Assessment; Zidovudine | 1997 |
[Long-term observation on children. HIV-positive pregnant women: AZT therapy to be continued].
Topics: Acquired Immunodeficiency Syndrome; Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 1999 |
[Response of fetal macrophages in the placenta of pregnant HIV-positive patients with and without antiretroviral treatment].
Topics: Antiviral Agents; Didanosine; Female; HIV Infections; HIV Seropositivity; Humans; Macrophages; Pregnancy; Pregnancy Complications, Infectious; Retroviridae; Zidovudine | 1999 |
Long-term immunotherapy in HIV infection, combined with short-term antiretroviral treatment.
Topics: Adult; AIDS Vaccines; Anti-HIV Agents; Combined Modality Therapy; Data Interpretation, Statistical; Double-Blind Method; Female; HIV Envelope Protein gp160; HIV Seropositivity; HIV-1; Humans; Immunotherapy; Male; Time Factors; Vaccines, Synthetic; Zidovudine | 1999 |
Altered pharmacokinetics of indinavir by a novel nonnucleoside reverse transcriptase inhibitor (HBY-097): a pharmacokinetic evaluation in HIV-positive patients.
Topics: Adult; Antiviral Agents; Area Under Curve; Drug Interactions; Drug Therapy, Combination; Exanthema; Female; Gastrointestinal Diseases; HIV Protease Inhibitors; HIV Seropositivity; Humans; Indinavir; Male; Middle Aged; Quinoxalines; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500/microL.
Topics: Adult; Blood Transfusion; CD4 Immunoadhesins; CD4 Lymphocyte Count; Cesarean Section; Chorioamnionitis; Cohort Studies; Delivery, Obstetric; Endometritis; Female; HIV Antibodies; HIV Infections; HIV Seropositivity; Humans; Immunoglobulins, Intravenous; Obstetric Labor Complications; Pregnancy; Pregnancy Complications, Infectious; Wound Infection; Zidovudine | 2000 |
Influence of prior exposure to zidovudine on stavudine phosphorylation in vivo and ex vivo.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Female; HIV Seropositivity; Humans; Male; Monocytes; Phosphorylation; Stavudine; Zidovudine | 2001 |
Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection.
Topics: Adult; Anti-HIV Agents; Central Nervous System Diseases; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Motor Skills; Stavudine; Zalcitabine; Zidovudine | 2001 |
Long-term effects of high-dose zidovudine treatment on neuropsychological performance in mildly symptomatic HIV-positive patients: results of a randomized, double-blind, placebo-controlled investigation.
Topics: Adult; Anti-HIV Agents; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; HIV Seropositivity; Humans; Male; Neuropsychological Tests; Time; Treatment Outcome; Zidovudine | 2001 |
Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Male; Middle Aged; Quality of Life; Zalcitabine; Zidovudine | 1997 |
Combination shows reduction in viral levels.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV; HIV Protease Inhibitors; HIV Seropositivity; Humans; Indinavir; Lamivudine; Time Factors; Zidovudine | 1996 |
Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
Topics: Adolescent; Adult; Anti-HIV Agents; Chi-Square Distribution; Double-Blind Method; Drug Administration Schedule; Female; Gestational Age; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prognosis; Statistics, Nonparametric; Treatment Outcome; Zidovudine | 2001 |
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations.
Topics: Anti-HIV Agents; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Mutation; Stavudine; Treatment Failure; Zidovudine | 2001 |
Intrapartum and neonatal zidovudine treatment in reduction of perinatal HIV-1 transmission in Bangkok.
Topics: Administration, Oral; Adult; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Primary Prevention; Thailand; Treatment Outcome; Zidovudine | 2001 |
[Efficacy and tolerance of dideoxynucleosides in HIV infection].
Topics: Acquired Immunodeficiency Syndrome; HIV Seropositivity; Humans; Zalcitabine; Zidovudine | 1992 |
The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals.
Topics: AIDS-Related Complex; beta 2-Microglobulin; Biomarkers; Biopterins; CD4-Positive T-Lymphocytes; Double-Blind Method; Drug Administration Schedule; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; Neopterin; Zidovudine | 1992 |
Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group.
Topics: Anemia; CD4-Positive T-Lymphocytes; Double-Blind Method; Drug Administration Schedule; Female; HIV Seropositivity; Humans; Male; Neutropenia; Risk Factors; Thrombocytopenia; Zidovudine | 1992 |
One-year follow-up on the safety and efficacy of isoprinosine for human immunodeficiency virus infection. Scandinavian Isoprinosine Study Group.
Topics: Acquired Immunodeficiency Syndrome; Double-Blind Method; Female; Follow-Up Studies; HIV Seropositivity; Humans; Inosine Pranobex; Male; Scandinavian and Nordic Countries; Survival Analysis; Time Factors; Zidovudine | 1992 |
The effect of antiviral therapy on the natural history of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Hemophilia A; HIV Infections; HIV Seropositivity; Humans; Time Factors; Zidovudine | 1992 |
Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; CD4 Antigens; Didanosine; Female; Granulocytes; Hemoglobins; HIV Seropositivity; Humans; Leukocyte Count; Male; Platelet Count; T-Lymphocyte Subsets; Time Factors; Zidovudine | 1992 |
Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy.
Topics: Autoradiography; DNA Probes; DNA Replication; DNA, Mitochondrial; Drug Administration Schedule; HIV Seropositivity; Humans; Mitochondria, Muscle; Myositis; Zidovudine | 1991 |
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; CD4-Positive T-Lymphocytes; Evaluation Studies as Topic; Follow-Up Studies; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; Male; Pentamidine; Pneumonia, Pneumocystis; Prospective Studies; Regression Analysis; Risk Factors; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1991 |
Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Diseases; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Opportunistic Infections; Prospective Studies; Vincristine; Zidovudine | 1991 |
HIV-seropositive thrombocytopenia: the action of zidovudine.
Topics: Adult; Didanosine; Female; HIV Seropositivity; Humans; Male; Middle Aged; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Thrombocytopenia; Zidovudine | 1991 |
Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Child; Child, Preschool; Cohort Studies; Hemophilia A; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; London; Longitudinal Studies; Lymphocytes; Middle Aged; Risk Factors; Treatment Outcome; Zidovudine | 1991 |
Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Female; Hemophilia A; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; Male; Placebos; Sexual Partners; T-Lymphocytes, Helper-Inducer; Zidovudine | 1991 |
Zidovudine for symptomless HIV infection.
Topics: Acquired Immunodeficiency Syndrome; CD4 Antigens; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Tolerance; Health Policy; HIV Seropositivity; Humans; United States; United States Food and Drug Administration; Zidovudine | 1990 |
[Randomized comparative study of secondary prevention of Pneumocystis carinii pneumonia in patients with acquired immunologic deficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Administration, Inhalation; Adult; Female; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Pentamidine; Pneumonia, Pneumocystis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Zidovudine | 1990 |
Long-term combined rIFN-alpha-2a and zidovudine therapy for HIV-associated Kaposi's sarcoma: clinical consequences and side effects.
Topics: Adult; Cell Count; Granulocytes; HIV Seropositivity; HIV-1; Humans; Interferon Type I; Male; Neoplasm Staging; Sarcoma, Kaposi; Time Factors; Zidovudine | 1990 |
Treatment dilemmas for HIV infected haemophiliacs.
Topics: Double-Blind Method; Female; Hemophilia A; HIV Seropositivity; Humans; Male; Psychotherapy, Group; Surveys and Questionnaires; Zidovudine | 1989 |
AIDS in Arkansas. AMS Special Committee on AIDS. Update December 1989: results of controlled clinical trials of zidovudine in early HIV infection.
Topics: AIDS-Related Complex; Clinical Trials as Topic; HIV Infections; HIV Seropositivity; Humans; Randomized Controlled Trials as Topic; Zidovudine | 1989 |
Zidovudine in symptomless HIV infection.
Topics: AIDS-Related Complex; Clinical Trials as Topic; HIV Seropositivity; Humans; Multicenter Studies as Topic; Random Allocation; Time Factors; Zidovudine | 1989 |
Clinical trials of zidovudine in HIV infection.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Resistance, Microbial; HIV Seropositivity; Humans; Random Allocation; Zidovudine | 1989 |
Concorde remains aloft.
Topics: CD4-Positive T-Lymphocytes; Double-Blind Method; France; HIV Seropositivity; Humans; Leukocyte Count; Multicenter Studies as Topic; United States; Zidovudine | 1989 |
[AIDS. Trial with Retrovir for HIV-positive subjects].
Topics: Clinical Trials as Topic; HIV Seropositivity; Humans; Random Allocation; Zidovudine | 1989 |
[HIV positive: when to begin azidothymidine (AZT)?].
Topics: Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; HIV Seropositivity; Humans; Zidovudine | 1989 |
AIDS. European trials of AZT to continue.
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Europe; HIV Seropositivity; Humans; Random Allocation; Zidovudine | 1989 |
Zidovudine treatment of AIDS and ARC in Denmark 1987.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4 Antigens; Clinical Trials as Topic; HIV Antigens; HIV Seropositivity; Humans; Randomized Controlled Trials as Topic; Zidovudine | 1989 |
[Early treatment with zidovudine; a turning point in the campaign against AIDS?].
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; AIDS-Related Complex; Clinical Trials as Topic; HIV Seropositivity; Humans; Research Design; Zidovudine | 1989 |
HIV therapeutics: an emerging science.
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Drug Therapy, Combination; HIV Seropositivity; Humans; Zidovudine | 1988 |
Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). A prospective study. The Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome (AIDS).
Topics: Adult; Anemia; Double-Blind Method; Female; HIV Seropositivity; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Thrombocytopenia; Zidovudine | 1988 |
387 other study(ies) available for zidovudine and AIDS Seroconversion
Article | Year |
---|---|
Progression of non-anemic macrocytosis to anemia in HIV-positive persons receiving zidovudine-containing regimens in a resource-limited setting.
Topics: Adult; Anemia; Anti-HIV Agents; Female; HIV Infections; HIV Seropositivity; Humans; Male; Retrospective Studies; Zidovudine | 2022 |
Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon.
Topics: Adolescent; Anti-HIV Agents; Cameroon; Drug Resistance, Viral; Follow-Up Studies; Health Facilities; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nevirapine; Retrospective Studies; Viral Load; Zidovudine | 2022 |
Assessment of lamivudine, zidovudine, lopinavir, and ritonavir plasma levels in HIV-positive pregnant women: Drug monitoring application to improve patient safety.
Topics: Adult; Anti-HIV Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Female; HIV Seropositivity; Humans; Lamivudine; Lopinavir; Patient Safety; Pregnancy; Ritonavir; Tandem Mass Spectrometry; Viral Load; Zidovudine | 2020 |
Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa.
Topics: Administration, Oral; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Resistance, Viral; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Epidemics; Female; HIV Seropositivity; HIV-1; Humans; Lamivudine; Pre-Exposure Prophylaxis; Retrospective Studies; South Africa; Treatment Outcome; Viral Load; Young Adult; Zidovudine | 2020 |
Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Treatment Failure; Treatment Outcome; Uganda; Viral Load; Zidovudine | 2019 |
Demographic and management trends among HIV-positive pregnant women over 10 years at one Canadian urban hospital.
Topics: Adolescent; Adult; Africa; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Canada; Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Viral Load; Zidovudine | 2014 |
Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dried Blood Spot Testing; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Papua New Guinea; Reverse Transcriptase Inhibitors; Stavudine; Treatment Failure; Viral Load; Young Adult; Zidovudine | 2014 |
Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV Seropositivity; Humans; Incidence; Lamivudine; Lopinavir; Male; Medication Adherence; Middle Aged; Post-Exposure Prophylaxis; Quebec; Ritonavir; Tenofovir; Young Adult; Zidovudine | 2015 |
[A case of acquired encephalopathy in a child. A cause that we thought had disappeared].
Topics: AIDS Dementia Complex; Anti-HIV Agents; Anti-Infective Agents; Drug Therapy, Combination; Female; Fluconazole; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Polymerase Chain Reaction; Pyrimidinones; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2008 |
Confluent molluscum contagiosum covering the eyelids of an HIV-positive child.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Drug Therapy, Combination; Eye Infections, Viral; Eyelid Diseases; HIV Seropositivity; Humans; Lamivudine; Male; Molluscum Contagiosum; Nevirapine; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Zidovudine | 2009 |
[Comparative study of two anti-antiretroviral protocols used for treatment of a cohort of HIV 1-positive patients followed at the Institute of Public Health and Hygiene in Dakar, Senegal].
Topics: Academies and Institutes; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Seropositivity; HIV-1; Humans; Hygiene; Lamivudine; Nevirapine; Public Health; Quality of Life; Retrospective Studies; Senegal; Survival Analysis; Treatment Outcome; Zidovudine | 2011 |
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach.
Topics: Adult; Anti-HIV Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; Goals; Healthy People Programs; HIV Infections; HIV Seropositivity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Male; Nevirapine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Public Health; United Nations; Zidovudine | 2011 |
Management of needlestick injuries: a house officer who has a needlestick.
Topics: Anti-HIV Agents; Blood-Borne Pathogens; Drug Combinations; Emergency Service, Hospital; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Internship and Residency; Lamivudine; Male; Needlestick Injuries; Occupational Exposure; Physicians; Post-Exposure Prophylaxis; Risk; United States; Zidovudine | 2012 |
The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.
Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiomyopathies; Cardiotonic Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Digoxin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Pregnancy; Prenatal Exposure Delayed Effects; Proportional Hazards Models; Prospective Studies; Treatment Outcome; United States; Zalcitabine; Zidovudine | 2012 |
Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy.
Topics: Adenine; Adult; Cross-Sectional Studies; Drug Administration Schedule; Drug Resistance, Viral; Female; Genotype; HIV Seropositivity; HIV-1; Humans; Male; Mutation, Missense; Nigeria; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2013 |
[A case of vitiligo occurring after initiation of antiretroviral treatment and disappearing during this treatment: autoimmune IRIS syndrome?].
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Male; Viral Load; Vitiligo; Zidovudine | 2012 |
Nevirapine inhibits the anti-HIV activity of CD8+ cells.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniques; HIV Infections; HIV Seropositivity; HIV-1; Humans; Nevirapine; RNA, Viral; Zidovudine | 2013 |
Sustained high proportion of zidovudine-resistant HIV variants despite prolonged substitution of zidovudine by other nucleoside reverse transcriptase inhibitors.
Topics: Adaptation, Physiological; Adult; Anti-HIV Agents; Dideoxynucleosides; Drug Resistance, Viral; Female; Genetic Variation; Genotype; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 2002 |
Attitudes of HIV-positive women toward zidovudine therapy during pregnancy.
Topics: Anti-HIV Agents; Attitude to Health; Female; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Zidovudine | 2002 |
Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.
Topics: Adult; Anti-HIV Agents; Breast Feeding; CD4 Lymphocyte Count; Female; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Male; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Third; Prenatal Care; Prospective Studies; Risk Factors; Rural Health; Treatment Outcome; Viral Load; Virus Replication; Zidovudine | 2002 |
Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados.
Topics: Adult; Barbados; Case-Control Studies; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; Humans; Incidence; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Probability; Prospective Studies; Risk Factors; Survival Analysis; Zidovudine | 2003 |
[Mother-to-child transmission of HIV].
Topics: Anti-HIV Agents; Cesarean Section; Female; Follow-Up Studies; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Norway; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Risk Factors; Zidovudine | 2003 |
Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Female; Hematopoiesis; Hemoglobins; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Lymphocyte Subsets; Maternal-Fetal Exchange; Neutrophils; Platelet Count; Pregnancy; Pregnancy Complications, Infectious; Time Factors; Zidovudine | 2003 |
Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
Topics: Acidosis, Lactic; Adult; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cohort Studies; Confidence Intervals; Female; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactic Acid; Male; Monitoring, Physiologic; Odds Ratio; Perinatal Care; Pregnancy; Probability; Prognosis; Prospective Studies; Risk Assessment; Zidovudine | 2003 |
Pregnancy-related changes in the longer-term management of HIV-infected women in Europe.
Topics: Abnormalities, Multiple; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Counseling; Delivery, Obstetric; Europe; Female; Health Care Surveys; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Postnatal Care; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Surveys and Questionnaires; Zidovudine | 2003 |
[Hypersensitive reaction to abacavir or syphilitic hepatitis?].
Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Ethylenediamines; HIV Seropositivity; Humans; Lamivudine; Male; Syphilis; Zidovudine | 2003 |
Relationship between human papilloma virus infection and abnormal Pap smear in HIV-seropositive women at Siriraj Hospital.
Topics: Adult; Anti-HIV Agents; Female; HIV Seropositivity; Humans; Papanicolaou Test; Papillomaviridae; Papillomavirus Infections; Prevalence; Thailand; Uterine Cervical Dysplasia; Vaginal Smears; Zidovudine | 2003 |
Sharing the benefits of HIV/AIDS research with resource-poor countries: AZT for pregnant women in Africa?
Topics: Africa; AIDS Vaccines; Biomedical Research; Developed Countries; Developing Countries; Drug Costs; Female; Health Services Accessibility; HIV Infections; HIV Seropositivity; Human Experimentation; Humans; Infectious Disease Transmission, Vertical; Moral Obligations; Pregnancy; Pregnant Women; Research Subjects; Social Justice; Zidovudine | 1997 |
Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV.
Topics: Adult; Anti-HIV Agents; Brazil; Chemoprevention; Cohort Studies; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Lamivudine; Male; Patient Acceptance of Health Care; Sexual Behavior; Surveys and Questionnaires; Zidovudine | 2004 |
Drug-testing on seropositive pregnant women in the developing world: moral and legal implications.
Topics: AIDS Serodiagnosis; Breast Feeding; Clinical Trials as Topic; Compensation and Redress; Confidentiality; Consent Forms; Counseling; Developing Countries; Disclosure; Drugs, Investigational; Female; Guidelines as Topic; Health Services Accessibility; HIV Infections; HIV Seropositivity; Human Experimentation; Human Rights; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Internationality; Mothers; Personal Autonomy; Pregnancy; Pregnant Women; Research Subjects; Social Justice; Zidovudine | 2000 |
Associated risk factors of human papillomavirus cervical infection among human immunodificiency virus-seropositive women at Siriraj Hospital.
Topics: Adult; Anti-HIV Agents; Chi-Square Distribution; Cross-Sectional Studies; Female; HIV Seropositivity; Humans; Logistic Models; Papanicolaou Test; Papillomaviridae; Papillomavirus Infections; Risk Factors; Thailand; Uterine Cervical Dysplasia; Vaginal Smears; Zidovudine | 2004 |
[Antiretroviral therapy of acute HIV-infection].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Female; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Lymphocyte Count; Male; Nevirapine; Viral Load; Zidovudine | 2004 |
HIV seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in greater Kingston, Jamaica.
Topics: Adolescent; Adult; Female; HIV Infections; HIV Seropositivity; HIV Seroprevalence; Humans; Infectious Disease Transmission, Vertical; Jamaica; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Program Evaluation; Zidovudine | 2004 |
A new challenge for the neuroradiologist: MR recognition of mitochondrial dysfunction in children born of HIV-seropositive mothers on antiretroviral therapy.
Topics: Anti-HIV Agents; HIV Seropositivity; Humans; Infant, Newborn; Magnetic Resonance Imaging; Mitochondrial Encephalomyopathies; Mothers; Zidovudine | 2005 |
Cerebral MR imaging in uninfected children born to HIV-seropositive mothers and perinatally exposed to zidovudine.
Topics: Anti-HIV Agents; Brain; Child, Preschool; Female; HIV Seropositivity; Humans; Infant; Magnetic Resonance Imaging; Male; Mitochondrial Encephalomyopathies; Mothers; Pilot Projects; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Zidovudine | 2005 |
Sociodemographic factors associated with participation by HIV-1-positive pregnant women in an intervention to prevent mother-to-child transmission of HIV in Cote d'Ivoire.
Topics: Adolescent; Adult; Anti-HIV Agents; Cote d'Ivoire; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infectious Disease Transmission, Vertical; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Socioeconomic Factors; Zidovudine | 2005 |
At what cost?: an argument against mandatory AZT treatment of HIV-positive pregnant women.
Topics: Civil Rights; Coercion; Female; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Mandatory Programs; Mandatory Testing; Pregnancy; Pregnant Women; State Government; Supreme Court Decisions; Treatment Refusal; United States; Zidovudine | 1997 |
Case records of the Massachusetts General Hospital. Case 32-2005. A 34-year-old HIV-positive woman who desired to become pregnant.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cesarean Section; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Papillomaviridae; Papillomavirus Infections; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Uterine Cervicitis; Viral Load; Zidovudine | 2005 |
Survival analysis using auxiliary variables via non-parametric multiple imputation.
Topics: Biometry; CD4 Lymphocyte Count; Clinical Trials as Topic; HIV Seropositivity; Humans; Kaplan-Meier Estimate; Placebo Effect; Survival Analysis; Zidovudine | 2006 |
Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates.
Topics: Anti-HIV Agents; Enterocolitis, Necrotizing; HIV Seropositivity; Humans; Infant, Newborn; Lamivudine; Male; Nevirapine; Risk Factors; Zidovudine | 2006 |
[Assessment of a programme of prevention of mother-to-child transmission of HIV in Abidjan, Ivory Coast (1999-20002)].
Topics: Breast Feeding; Cote d'Ivoire; Female; HIV Infections; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2006 |
Lung cancer as an immune reconstitution disease in an HIV-1 positive man receiving HAART.
Topics: Adult; Antiretroviral Therapy, Highly Active; Carcinoma, Small Cell; Fatal Outcome; HIV Seropositivity; Humans; Lamivudine; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Ritonavir; Saquinavir; Zidovudine | 2006 |
Proton Spectroscopy in a Cross-Section of HIV-Positive Asymptomatic Patients Receiving Immediate Compared with Deferred Zidovudine (Concorde Study).
Topics: HIV Infections; HIV Seropositivity; Humans; Magnetic Resonance Spectroscopy; Protons; Spectrum Analysis; Zidovudine | 1997 |
Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion.
Topics: Acute Disease; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; Follow-Up Studies; Histocompatibility Testing; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Retrospective Studies; RNA, Viral; Stavudine; Treatment Outcome; Zidovudine | 2006 |
[Adherence, pharmacokinetic "tolerance capacity" and HIV resistance development].
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Diagnosis, Differential; DNA Mutational Analysis; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Nelfinavir; Treatment Refusal; Viral Load; Zidovudine | 2006 |
Increased haemoglobin A2 percentage in HIV infection: disease or treatment?
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Hemoglobin A2; HIV Infections; HIV Seropositivity; Humans; Prospective Studies; Zidovudine | 2007 |
[Update on HIV infection in Mayotte].
Topics: Adult; Anti-HIV Agents; Comoros; Dideoxynucleosides; Drug Combinations; Female; Heterosexuality; HIV Infections; HIV Seropositivity; Homosexuality; Humans; Lamivudine; Male; Middle Aged; Transfusion Reaction; Viremia; Zidovudine | 2007 |
Myocardial Fas ligand expression increases susceptibility to AZT-induced cardiomyopathy.
Topics: Animals; Anti-HIV Agents; Apoptosis; Blotting, Western; Cardiomyopathies; Cardiomyopathy, Dilated; Echocardiography; Fas Ligand Protein; HIV Seropositivity; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Troponin I; Zidovudine | 2007 |
Frequent detection of acute HIV infection in pregnant women.
Topics: Acute Disease; Algorithms; Anti-HIV Agents; Female; Follow-Up Studies; HIV; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; North Carolina; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Second; Prenatal Care; Prevalence; RNA, Viral; Zidovudine | 2007 |
Resituating the principle of equipoise: justice and access to care in non-ideal conditions.
Topics: Anti-HIV Agents; Child; Child, Preschool; Controlled Clinical Trials as Topic; Delivery of Health Care; Developing Countries; Education; Ethical Analysis; Ethical Theory; Ethics, Research; Female; Health Services Accessibility; HIV Seropositivity; Humans; Infant; London; Male; Moral Obligations; Nutrition Policy; Personal Autonomy; Pregnancy; Pregnancy Complications, Infectious; Research Design; Research Personnel; Social Justice; Therapeutic Human Experimentation; Uncertainty; United States; Zidovudine | 2007 |
Transmembrane P-glycoprotein (P-gp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug-unrelated function.
Topics: Adult; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Didanosine; Female; HIV Seropositivity; Humans; Immunophenotyping; Interleukin-2; Lymphocyte Activation; Lymphocytes; Male; Phytohemagglutinins; Zalcitabine; Zidovudine | 1995 |
Clinical significance of serum 2,5-oligoadenylate synthetase and soluble interleukin-2 receptor in hemophiliacs positive and negative for human immunodeficiency virus type 1.
Topics: 2',5'-Oligoadenylate Synthetase; Adolescent; Adult; Biomarkers; Hemophilia A; Hepatitis C; HIV Seronegativity; HIV Seropositivity; Humans; Middle Aged; Receptors, Interleukin-2; Zidovudine | 1994 |
Unsuspected HIV infection presenting in first year of life.
Topics: Female; HIV Infections; HIV Seropositivity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Mass Screening; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1995 |
Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells.
Topics: Antiviral Agents; Cells, Cultured; Chromatography, High Pressure Liquid; Dideoxynucleotides; Half-Life; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Monocytes; Radioimmunoassay; Reverse Transcriptase Inhibitors; T-Lymphocytes; Zidovudine | 1994 |
Transmission of zidovudine-resistant HIV-1 through heterosexual contacts.
Topics: Codon; Coitus; Drug Resistance, Microbial; Female; HIV Infections; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Male; Point Mutation; RNA-Directed DNA Polymerase; Sexual Behavior; Zidovudine | 1994 |
Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Cell Cycle; Cells, Cultured; Flow Cytometry; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Kinetics; Lymphocytes; Reference Values; Thymidine Kinase; Zidovudine | 1995 |
[Early hematological consequences in infants born to HIV seropositive mothers treated with zidovudine during pregnancy].
Topics: Antiviral Agents; Female; Hematology; HIV Seropositivity; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Loss of periodontal attachment in HIV-seropositive military personnel.
Topics: Adolescent; Adult; Age Factors; AIDS-Related Opportunistic Infections; Antiviral Agents; Candidiasis, Oral; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; Forecasting; Gingival Diseases; HIV Infections; HIV Seropositivity; Humans; Logistic Models; Male; Middle Aged; Military Personnel; Odds Ratio; Periodontal Attachment Loss; Sex Factors; Smoking; Zidovudine | 1995 |
Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Analysis of Variance; Bisexuality; CD4-CD8 Ratio; Disease Progression; Follow-Up Studies; HIV Antibodies; HIV Core Protein p24; HIV Envelope Protein gp41; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Male; Multivariate Analysis; Predictive Value of Tests; Prognosis; Time Factors; Zidovudine | 1995 |
Acceptance of zidovudine (AZT) in early HIV disease: the role of health beliefs.
Topics: Adult; Cognitive Dissonance; Health Behavior; HIV Seropositivity; Homosexuality, Male; Humans; Internal-External Control; Male; Patient Compliance; Surveys and Questionnaires; Treatment Refusal; Zidovudine | 1995 |
Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. The New York City Perinatal HIV Transmission Collaborative Study Group.
Topics: Case-Control Studies; CD4-CD8 Ratio; Drug Resistance, Microbial; Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Retrospective Studies; Zidovudine | 1995 |
Antiretroviral therapy suppresses the constitutive production of interleukin-1 associated with human immunodeficiency virus infection.
Topics: Adult; Female; HIV Seropositivity; HIV-1; Humans; Interleukin-1; Lipopolysaccharides; Male; Middle Aged; Monocytes; Tumor Necrosis Factor-alpha; Zidovudine | 1995 |
Seizure associated with zidovudine.
Topics: Adult; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Medical Staff, Hospital; Needlestick Injuries; Seizures; Zidovudine | 1995 |
Is zidovudine a prophylactic treatment for health care workers?
Topics: Female; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Needlestick Injuries; Nurses; Zidovudine | 1995 |
Chemotherapeutic options in HIV infection.
Topics: Analysis of Variance; Antiviral Agents; Biotransformation; Cell Line; Cells, Cultured; Chromatography, High Pressure Liquid; Didanosine; Drug Interactions; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lymphocytes; Microbial Sensitivity Tests; Tumor Cells, Cultured; Zidovudine | 1994 |
Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Amino Acid Sequence; Drug Resistance, Microbial; Female; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Male; Molecular Sequence Data; Mutation; RNA-Directed DNA Polymerase; Zidovudine | 1993 |
Early identification of human immunodeficiency virus-infected asymptomatic subjects susceptible to zidovudine by quantitative viral coculture and reverse transcription-linked polymerase chain reaction.
Topics: Base Sequence; DNA, Viral; HIV; HIV Seropositivity; Humans; Molecular Sequence Data; Monocytes; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Transcription, Genetic; Zidovudine | 1993 |
Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay.
Topics: Acyclovir; CD4 Lymphocyte Count; Didanosine; Disease Progression; DNA, Single-Stranded; Drug Therapy, Combination; Gene Amplification; Genes, pol; HIV Seropositivity; HIV-1; Humans; Longitudinal Studies; Nucleic Acid Hybridization; Oligonucleotide Probes; Reproducibility of Results; RNA, Viral; Sensitivity and Specificity; Zidovudine | 1995 |
HIV infection and drug use: influence on cognitive function.
Topics: Cognition; Female; HIV Infections; HIV Seropositivity; Humans; Male; Neurologic Examination; Prospective Studies; Substance-Related Disorders; Zidovudine | 1995 |
Use of thalidomide in treatment and maintenance of idiopathic esophageal ulcers in HIV+ individuals.
Topics: Acquired Immunodeficiency Syndrome; Adult; Esophageal Diseases; Female; HIV Seropositivity; HIV-1; Humans; Prednisone; Thalidomide; Ulcer; Zidovudine | 1995 |
Prognostic value of combined response markers among human immunodeficiency virus-infected persons: possible aid in the decision to change zidovudine monotherapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; beta 2-Microglobulin; Biomarkers; Biopterins; CD4 Lymphocyte Count; Decision Making; Follow-Up Studies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Neopterin; Prognosis; Zidovudine | 1995 |
Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies.
Topics: Acquired Immunodeficiency Syndrome; Age Factors; Analysis of Variance; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Genes, MHC Class I; Genes, MHC Class II; Haplotypes; Hemophilia A; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; HIV Seropositivity; HIV-1; Humans; Incidence; Nuclear Family; Proportional Hazards Models; Retrospective Studies; Zidovudine | 1995 |
Case study: ethics consultation.
Topics: Adult; Ethicists; Ethics Consultation; Ethics, Professional; Female; Fertilization in Vitro; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Patient Selection; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; DNA; HIV Core Protein p24; HIV Infections; HIV Seropositivity; HIV-1; Humans; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Reproducibility of Results; RNA, Viral; Time Factors; Zidovudine | 1995 |
A follow-up study of neuropsychological functioning in AIDS-patients. Prognostic significance and effect of zidovudine therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Follow-Up Studies; HIV Seropositivity; Humans; Middle Aged; Neuropsychological Tests; Prognosis; Zidovudine | 1995 |
The predictive value of T cell function in vitro and pre-AIDS zidovudine use for survival after AIDS diagnosis in a cohort of homosexual men in Amsterdam.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Analysis of Variance; Antigens, CD; Biomarkers; CD4-CD8 Ratio; Cells, Cultured; Cohort Studies; Follow-Up Studies; HIV; HIV Seropositivity; Homosexuality, Male; Humans; Lymphocyte Activation; Male; Multivariate Analysis; Netherlands; Predictive Value of Tests; Prognosis; Prospective Studies; Survival Analysis; T-Lymphocyte Subsets; T-Lymphocytes; Time Factors; Zidovudine | 1995 |
Screening for HIV infection. The time has not yet come.
Topics: Acquired Immunodeficiency Syndrome; Adult; Blotting, Western; Disclosure; Enzyme-Linked Immunosorbent Assay; Female; Health Promotion; HIV Seropositivity; Humans; Male; Risk-Taking; United States; Zidovudine | 1994 |
Perinatal human immunodeficiency virus testing. Provisional Committee on Pediatric AIDS, American Academy of Pediatrics.
Topics: Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Informed Consent; Parental Consent; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Risk Assessment; Voluntary Programs; Zidovudine | 1995 |
Cataplexy associated with midbrain lesion.
Topics: Adult; AIDS-Related Opportunistic Infections; Cataplexy; HIV Seropositivity; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Cerebral; Zidovudine | 1995 |
Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.
Topics: Adult; Aged; beta 2-Microglobulin; Biomarkers; Biopterins; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Longitudinal Studies; Male; Middle Aged; Monitoring, Immunologic; Neopterin; Zidovudine | 1994 |
AIDS presenting as progressive multifocal leukoencephalopathy with clinical response to zidovudine.
Topics: Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Biopsy; Brain; Dose-Response Relationship, Drug; HIV Seropositivity; HIV-1; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Neurologic Examination; Polymerase Chain Reaction; Zidovudine | 1994 |
Quantitation of human immunodeficiency virus by culture and polymerase chain reaction in response to didanosine after long-term therapy with zidovudine.
Topics: Adult; CD4-Positive T-Lymphocytes; Didanosine; DNA, Viral; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; Middle Aged; Polymerase Chain Reaction; Proviruses; RNA, Viral; Time Factors; Zidovudine | 1994 |
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Didanosine; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Polymerase Chain Reaction; Proviruses; RNA, Viral; Time Factors; Transcription, Genetic; Zidovudine | 1994 |
A 3.5-year study of immune function in persons with hemophilia infusing recombinant factor VIII.
Topics: Adolescent; Adult; Aged; Antibody Formation; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Factor VIII; Follow-Up Studies; Hemophilia A; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Infant; Male; Middle Aged; Recombinant Proteins; T-Lymphocyte Subsets; Time Factors; Zidovudine | 1994 |
Phenotypically defined memory CD4+ cells are not selectively decreased in chronic HIV disease.
Topics: CD4-Positive T-Lymphocytes; Cohort Studies; Follow-Up Studies; HIV Seropositivity; Humans; Immunologic Memory; Immunophenotyping; Lymphocyte Activation; Male; Regression Analysis; Zidovudine | 1994 |
Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Candidiasis; CD4-Positive T-Lymphocytes; Cohort Studies; Hemophilia A; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; Logistic Models; London; Male; Pneumonia, Pneumocystis; Sensitivity and Specificity; Survival Analysis; Time Factors; Zidovudine | 1994 |
Lower socioeconomic status and shorter survival following HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; British Columbia; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Health Services; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Income; Male; Pneumonia, Pneumocystis; Regression Analysis; Socioeconomic Factors; Survival Rate; Zalcitabine; Zidovudine | 1994 |
Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
Topics: Adult; Age Factors; Antiviral Agents; beta 2-Microglobulin; Biomarkers; CD4 Lymphocyte Count; Cohort Studies; Comorbidity; Databases, Factual; Disease Progression; District of Columbia; Female; HIV Antibodies; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Immunoglobulin A; Italy; Life Tables; London; Male; Middle Aged; New York City; Ontario; Prognosis; Regression Analysis; Risk; Risk Factors; Scotland; Sex Factors; Sexual Behavior; Substance Abuse, Intravenous; Survival Analysis; Time Factors; Zidovudine | 1994 |
In vitro improvement of bone marrow-derived hematopoietic colony formation in HIV-positive patients by alpha-D-tocopherol and erythropoietin.
Topics: Adult; Cell Division; Cells, Cultured; Colony-Forming Units Assay; Erythroid Precursor Cells; Erythropoietin; Hematopoietic Stem Cells; HIV Seropositivity; Humans; Male; Vitamin E; Zidovudine | 1994 |
AIDS: when your patient refuses HIV testing.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Candidiasis, Oral; Diagnosis, Differential; Female; HIV Antibodies; HIV Seropositivity; HIV-1; Humans; Middle Aged; Nursing Assessment; Pneumonia, Pneumocystis; Treatment Refusal; Zidovudine | 1994 |
Zidovudine could stop HIV infection of babies.
Topics: Acquired Immunodeficiency Syndrome; Female; HIV Seropositivity; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Hyperosmolar nonketotic diabetic syndrome following treatment of human immunodeficiency virus infection with didanosine.
Topics: Adult; Blood Glucose; Didanosine; Female; HIV Infections; HIV Seropositivity; Humans; Hyperglycemia; Hyperglycemic Hyperosmolar Nonketotic Coma; Monitoring, Physiologic; Pregnancy; Pregnancy Complications, Infectious; Pregnancy in Diabetics; Zidovudine | 1994 |
Motor analysis predicts progression in HIV-associated brain disease.
Topics: Adult; AIDS Dementia Complex; Electrophysiology; Female; Follow-Up Studies; HIV Seropositivity; Humans; Magnetic Resonance Imaging; Male; Motor Activity; Neurologic Examination; Predictive Value of Tests; Prognosis; Time Factors; Tremor; Zidovudine | 1994 |
Effect of dipyridamole on zidovudine pharmacokinetics and short-term tolerance in asymptomatic human immunodeficiency virus-infected subjects.
Topics: Adult; Dipyridamole; Drug Combinations; Drug Interactions; HIV Seropositivity; Humans; Iodine Radioisotopes; Male; Orosomucoid; Zidovudine | 1994 |
The effect of zidovudine on neuropsychiatric measures in HIV-infected men.
Topics: CD4-Positive T-Lymphocytes; HIV Seropositivity; Humans; Leukocyte Count; Male; Neuropsychological Tests; Zidovudine | 1993 |
HIV and the aetiology of AIDS.
Topics: Acquired Immunodeficiency Syndrome; HIV Seropositivity; Humans; Public Health; Substance-Related Disorders; Zidovudine | 1993 |
Why anonymous?
Topics: Accidents, Occupational; Acquired Immunodeficiency Syndrome; Confidentiality; Disclosure; HIV Seropositivity; Humans; Occupational Diseases; Patients; Personnel, Hospital; Risk; Time Factors; Zidovudine | 1993 |
HIV seroconversion after occupational exposure despite early prophylactic zidovudine therapy.
Topics: Accidents, Occupational; Acquired Immunodeficiency Syndrome; Adult; Female; HIV Seropositivity; Humans; Middle Aged; Needlestick Injuries; Occupational Diseases; Personnel, Hospital; Time Factors; United Kingdom; Zidovudine | 1993 |
Erratic zidovudine bioavailability in HIV seropositive patients.
Topics: Adult; Biological Availability; CD4-Positive T-Lymphocytes; HIV Infections; HIV Seropositivity; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Zidovudine | 1993 |
After Concorde.
Topics: CD4-Positive T-Lymphocytes; Clinical Trials as Topic; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine | 1993 |
The Concorde trial.
Topics: Female; HIV Infections; HIV Seropositivity; Humans; Male; Patient Satisfaction; Scotland; Zidovudine | 1993 |
HIV seroconversion after occupational exposure despite early prophylactic zidovudine therapy.
Topics: Acquired Immunodeficiency Syndrome; Female; Health Personnel; HIV Seropositivity; Humans; Needlestick Injuries; Occupational Diseases; Zidovudine | 1993 |
Effect of antiretroviral therapy on the cerebrospinal fluid of patients seropositive for the human immunodeficiency virus.
Topics: Adult; beta 2-Microglobulin; Biopterins; CD4-Positive T-Lymphocytes; Cerebrospinal Fluid Proteins; Cohort Studies; Cross-Sectional Studies; Glucose; HIV Seropositivity; Humans; Leukocyte Count; Longitudinal Studies; Male; Middle Aged; Neopterin; Quinolinic Acid; Zidovudine | 1993 |
[Treatment failure of preventive zidovudine in maternal fetal transmission of HIV].
Topics: Adult; Amniotic Fluid; CD4-Positive T-Lymphocytes; Chromatography, High Pressure Liquid; Female; Fetal Blood; Fetal Diseases; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; Pregnancy; Pregnancy Complications, Infectious; Treatment Failure; Zidovudine | 1993 |
Does zidovudine delay development of AIDS? Analysis of data from observational cohorts.
Topics: Acquired Immunodeficiency Syndrome; Bias; Cohort Studies; HIV Seropositivity; Humans; Male; Proportional Hazards Models; Zidovudine | 1993 |
Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates.
Topics: CD4-Positive T-Lymphocytes; Cloning, Molecular; Codon; DNA, Viral; Genotype; HIV Core Protein p24; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; Male; Microbial Sensitivity Tests; Mutation; Proviruses; Virus Replication; Zidovudine | 1993 |
The effects of disease progression and zidovudine therapy on semen quality in human immunodeficiency virus type 1 seropositive men.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cross-Sectional Studies; HIV Seropositivity; HIV-1; Humans; Leukocytes; Male; Middle Aged; Semen; Severity of Illness Index; Sperm Count; Sperm Motility; Spermatozoa; Zidovudine | 1994 |
Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; CD4 Antigens; Female; Germany; HIV Seropositivity; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Retrospective Studies; Survival Rate; Zidovudine | 1994 |
Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Didanosine; Drug Resistance, Microbial; HIV Seropositivity; HIV-1; Humans; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Time Factors; Zalcitabine; Zidovudine | 1994 |
Iron overload in multiply transfused patients who are HIV seropositive.
Topics: Adult; Aged; Anemia; HIV Seropositivity; Humans; Iron; Liver; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Transfusion Reaction; Zidovudine | 1993 |
Surveillance study adds to database on seroconversion rates and zidovudine use after occupational exposures.
Topics: Databases, Factual; Health Personnel; HIV Seropositivity; Humans; Occupational Diseases; Population Surveillance; Zidovudine | 1993 |
Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Hepatitis B; HIV Seropositivity; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Zidovudine | 1993 |
Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiviral Agents; Bisexuality; Cohort Studies; HIV Seropositivity; Homosexuality; Humans; Male; Pentamidine; Pneumonia, Pneumocystis; Prospective Studies; United States; Zidovudine | 1993 |
Painful symptoms reported by ambulatory HIV-infected men in a longitudinal study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Anti-Inflammatory Agents, Non-Steroidal; Depression; HIV Infections; HIV Seropositivity; Humans; Longitudinal Studies; Male; Outpatients; Pain; Psychiatric Status Rating Scales; Zidovudine | 1993 |
[Management of HIV-seropositive newborn infants. Personal experience apropos of 179 cases].
Topics: Age Factors; AIDS-Related Opportunistic Infections; Female; Follow-Up Studies; HIV Seropositivity; Humans; Infant; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Vaccination; Zidovudine | 1993 |
Widow given aid to sue over use of zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Blood Component Transfusion; Drug Industry; HIV Seropositivity; Humans; Male; Malpractice; United Kingdom; Zidovudine | 1993 |
A follow-up study of neuropsychological function in asymptomatic HIV-infected patients.
Topics: Adolescent; Adult; AIDS Dementia Complex; CD4-CD8 Ratio; Female; Follow-Up Studies; HIV Seropositivity; Humans; Leukocyte Count; Male; Middle Aged; Neuropsychological Tests; Zidovudine | 1993 |
Study of human immunodeficiency virus resistance to 2'-3'-dideoxyinosine and zidovudine in sequential isolates from pediatric patients on long-term therapy.
Topics: Child; Child, Preschool; Dideoxyadenosine; Drug Resistance, Microbial; Female; HIV; HIV Seropositivity; Humans; Infant; Male; Zidovudine | 1993 |
Cholestatic giant cell hepatitis associated with ultrastructural evidence of intrahepatic retroviral infection in a human immunodeficiency virus-seropositive infant.
Topics: AIDS-Related Opportunistic Infections; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Cholestasis; Giant Cells; Hepatitis, Viral, Human; Hepatomegaly; HIV Infections; HIV Seropositivity; Humans; Infant; Liver; Pentamidine; Pneumonia, Pneumocystis; Splenomegaly; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1993 |
Comparative study of the isolation of human immunodeficiency virus from the lung and peripheral blood of AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Bronchoalveolar Lavage Fluid; DNA, Viral; HIV Seropositivity; HIV-1; Humans; Lung; Polymerase Chain Reaction; Viremia; Zidovudine | 1993 |
Hepatomegaly with severe steatosis in HIV-seropositive patients.
Topics: Adult; Aspartate Aminotransferases; Fatty Liver; Female; Hepatomegaly; HIV Infections; HIV Seropositivity; Humans; Male; Middle Aged; Zidovudine | 1993 |
Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral protein.
Topics: AIDS-Related Complex; Antiviral Agents; CD4 Antigens; Cell Line; Cell Survival; Cytopathogenic Effect, Viral; HIV Seropositivity; HIV-1; Humans; Immunotoxins; N-Glycosyl Hydrolases; Plant Proteins; Ribosome Inactivating Proteins, Type 1; Zidovudine | 1993 |
Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus.
Topics: Adult; Drug Resistance, Microbial; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Mutation; Polymerase Chain Reaction; Time Factors; Zidovudine | 1995 |
Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood--France, United Kingdom, and United States, January 1988-August 1994.
Topics: Antiviral Agents; Blood-Borne Pathogens; Case-Control Studies; France; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Occupational Exposure; Risk Factors; United Kingdom; United States; Zidovudine | 1995 |
[Frequency and mode of use of testing for HIV infection in women hospitalized for childbirth].
Topics: Adult; Cross-Sectional Studies; Female; HIV Infections; HIV Seropositivity; Hospitals, Maternity; Humans; Pregnancy; Pregnancy Complications, Infectious; Rome; Zidovudine | 1995 |
Comparison of immunodeficiency and AIDS defining conditions in HIV negative and HIV positive men with haemophilia A.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; CD4 Lymphocyte Count; Factor VIII; Hemophilia A; HIV Seronegativity; HIV Seropositivity; Humans; Immunologic Deficiency Syndromes; Male; Middle Aged; Zidovudine | 1996 |
Commentary: non-HIV hypotheses must be studied more carefully.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Factor VIII; Hemophilia A; HIV Seropositivity; Humans; Zidovudine | 1996 |
Response: arguments contradict the "foreign protein-zidovudine" hypothesis.
Topics: Acquired Immunodeficiency Syndrome; Factor VIII; Hemophilia A; HIV; HIV Seropositivity; Humans; Risk Factors; Zidovudine | 1996 |
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
Topics: AIDS Serodiagnosis; Antiviral Agents; Cohort Studies; Delivery, Obstetric; DNA, Viral; Drug Resistance, Microbial; Female; Gestational Age; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk; RNA, Viral; Zidovudine | 1996 |
Statistical analysis of zidovudine (AZT) effect on CD4 cell counts in HIV disease.
Topics: Antiviral Agents; Bayes Theorem; CD4 Lymphocyte Count; Effect Modifier, Epidemiologic; Female; HIV Seropositivity; Humans; Immunocompetence; Longitudinal Studies; Male; Markov Chains; Monte Carlo Method; Regression Analysis; Treatment Outcome; Zidovudine | 1996 |
The cost-effectiveness of human immunodeficiency virus screening in pregnancy.
Topics: Cost-Benefit Analysis; Drug Costs; Female; HIV Infections; HIV Seropositivity; Humans; Mass Screening; Models, Statistical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1996 |
Decline in working memory associated with HIV infection. HNRC Group.
Topics: Adult; Antiviral Agents; Brain; HIV Seropositivity; Humans; Male; Memory Disorders; Severity of Illness Index; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Wechsler Scales; Zidovudine | 1995 |
Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine.
Topics: Base Sequence; CD4 Lymphocyte Count; DNA Primers; Genetic Variation; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Homosexuality, Male; Host-Parasite Interactions; Humans; Male; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; RNA, Viral; Time Factors; Virus Replication; Zidovudine | 1996 |
Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
Topics: Abortion, Induced; AIDS Serodiagnosis; Antiviral Agents; Cost of Illness; Cost Savings; Counseling; Drug Costs; Female; Health Care Costs; HIV Infections; HIV Seropositivity; HIV Seroprevalence; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Sensitivity and Specificity; United States; Voluntary Programs; Zidovudine | 1996 |
Compliance with AZT treatment regimen of HIV-seropositive injection drug users: a neglected issue.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Attitude to Health; HIV Seropositivity; Humans; Male; Middle Aged; Patient Compliance; Physician-Patient Relations; Research; Sample Size; Sampling Studies; Substance Abuse, Intravenous; Zidovudine | 1996 |
Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility.
Topics: Antiviral Agents; Codon; Drug Therapy, Combination; Genetic Variation; HeLa Cells; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Point Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Virus Replication; Zalcitabine; Zidovudine | 1996 |
Zidovudine absorption and small intestinal function in HIV seropositive patients.
Topics: Administration, Oral; Adult; Antiviral Agents; Diarrhea; HIV Seropositivity; Humans; Intestinal Absorption; Intestine, Small; Male; Middle Aged; Prospective Studies; Zidovudine | 1996 |
Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985.
Topics: Adult; Age Factors; Antiviral Agents; CD4 Lymphocyte Count; Disease Progression; Follow-Up Studies; Histocompatibility Testing; HIV Infections; HIV Seropositivity; Humans; Male; Statistics as Topic; Substance Abuse, Intravenous; United Kingdom; Zidovudine | 1996 |
The Edinburgh cohort of HIV-positive injecting drug users at 10 years after infection: a case-control study of the evolution of dementia.
Topics: Adult; AIDS Dementia Complex; Antiviral Agents; Case-Control Studies; CD4 Lymphocyte Count; Cognition; Disease Progression; Evoked Potentials, Auditory; Female; HIV Seropositivity; Humans; Male; Neuropsychological Tests; Psychomotor Performance; Substance Abuse, Intravenous; United Kingdom; Zidovudine | 1996 |
Quantification of zidovudine and individual zidovudine phosphates in peripheral blood mononuclear cells by a combined isocratic high performance liquid chromatography radioimmunoassay method.
Topics: Antiviral Agents; Chromatography, High Pressure Liquid; HIV Seropositivity; Humans; Leukocytes, Mononuclear; Radioimmunoassay; Zidovudine | 1996 |
The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men.
Topics: Anti-HIV Agents; Carrier State; Chronic Disease; Hepatitis B; HIV Seronegativity; HIV Seropositivity; Homosexuality, Male; Humans; Male; Retrospective Studies; Transaminases; Zidovudine | 1996 |
Quantification of low levels of human immunodeficiency virus (HIV) type 1 RNA in P24 antigen-negative, asymptomatic, HIV-positive patients by PCR.
Topics: Antiviral Agents; Evaluation Studies as Topic; HIV Core Protein p24; HIV Seropositivity; HIV-1; Humans; Interferon-alpha; Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Viremia; Zidovudine | 1996 |
Fatal toxic epidermolysis induced by zidovudine.
Topics: Adult; Anti-HIV Agents; Fatal Outcome; HIV Seropositivity; Humans; Male; Stevens-Johnson Syndrome; Zidovudine | 1996 |
Mitochondrial DNA levels in the brain of HIV-positive patients after zidovudine therapy.
Topics: AIDS Dementia Complex; Antiviral Agents; Brain Chemistry; Densitometry; DNA, Mitochondrial; HIV Seropositivity; Humans; Zidovudine | 1996 |
Abnormal expression of a 170-kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4+ and CD8+ T cells from patients with human immunodeficiency virus type 1 infection.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Female; Genes, MDR; HIV Seropositivity; Humans; Male; Rhodamine 123; Rhodamines; Zidovudine | 1996 |
Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine therapy.
Topics: Anti-HIV Agents; Biopterins; Chromatography, High Pressure Liquid; HIV Infections; HIV Seropositivity; Humans; Kynurenine; Neopterin; Quinolinic Acid; Radioimmunoassay; Time Factors; Tryptophan; Zidovudine | 1996 |
Needlestick injuries.
Topics: Accidents, Occupational; Acquired Immunodeficiency Syndrome; Health Personnel; HIV Seropositivity; HIV-1; Humans; Needlestick Injuries; Virus Replication; Zidovudine | 1996 |
Porphyrin abnormalities in acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Case-Control Studies; Feces; Female; Hepatitis C; Hepatitis C Antibodies; HIV Infections; HIV Seropositivity; Humans; Immunocompromised Host; Male; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Prospective Studies; Sexually Transmitted Diseases, Viral; Substance Abuse, Intravenous; Zidovudine | 1996 |
The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Alcohol Drinking; Amylases; Anti-HIV Agents; Appetite Stimulants; CD4 Lymphocyte Count; Didanosine; Dronabinol; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Seropositivity; Humans; Liver Function Tests; Male; Marijuana Smoking; Middle Aged; Pancreatitis, Alcoholic; Zalcitabine; Zidovudine | 1997 |
Medically compromised patients, Part II. Current trends in zidovudine chemoprophylaxis post HIV exposure.
Topics: Academic Medical Centers; Anti-HIV Agents; Chemoprevention; Dental Care for Chronically Ill; Dentistry; HIV Infections; HIV Seropositivity; Humans; Occupational Diseases; Occupational Exposure; Organizational Policy; Surveys and Questionnaires; Zidovudine | 1995 |
Interpersonal psychotherapy of a depressed, pregnant, HIV-positive woman.
Topics: Adult; Anti-HIV Agents; Depression; Female; HIV Seropositivity; Humans; Pregnancy; Prenatal Care; Psychotherapy; Transference, Psychology; Treatment Outcome; Zidovudine | 1997 |
[Syncitia inducing phenotype, zidovudine++ resistance and fast clinical progression in a child infected by HIV].
Topics: Anti-Infective Agents; Brain; Child; Fatal Outcome; HIV Seropositivity; Humans; Male; Phenotype; Pneumocystis Infections; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1997 |
Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Cohort Studies; Disease Progression; Female; HIV Seropositivity; Humans; Male; Middle Aged; Risk Factors; Treatment Outcome; Zidovudine | 1997 |
Mutations associated with zidovudine resistance in HIV-1 among recent seroconvertors.
Topics: Anti-HIV Agents; DNA, Viral; Drug Resistance, Microbial; Female; HIV Seropositivity; HIV-1; Humans; Male; Mutation; Zidovudine | 1997 |
Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection.
Topics: Brain; CD4 Lymphocyte Count; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Magnetic Resonance Spectroscopy; Male; Prospective Studies; Retrospective Studies; Zidovudine | 1997 |
Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
Topics: Adult; Amino Acid Sequence; Base Sequence; Didanosine; DNA, Viral; Female; Genes, env; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nevirapine; Nucleic Acid Heteroduplexes; Phylogeny; Pyridines; Reverse Transcriptase Inhibitors; Sequence Homology, Amino Acid; Zidovudine; Zimbabwe | 1997 |
Estimating the proportion of treatment effect explained by a surrogate marker.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Biomarkers; Double-Blind Method; Follow-Up Studies; HIV Seropositivity; Humans; Models, Statistical; Randomized Controlled Trials as Topic; Regression Analysis; Treatment Outcome; Zidovudine | 1997 |
Improving the cytogenetic response to interferon alpha by zidovudine (AZT) in an HIV-positive chronic myelogenous leukemia patient.
Topics: Adult; Anti-HIV Agents; Antineoplastic Agents; Drug Therapy, Combination; Hematologic Tests; HIV Seropositivity; Humans; Interferon Type I; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Recombinant Proteins; Zidovudine | 1997 |
Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir.
Topics: Anti-HIV Agents; Central Nervous System; Dideoxynucleosides; Drug Therapy, Combination; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy: identification of evolving metabolic patterns in relation to dementia and therapy.
Topics: Adult; Aged; AIDS Dementia Complex; Brain; Female; HIV Seropositivity; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Zidovudine | 1997 |
In vitro antimicrobial properties of azidothymidine (AZT).
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Bacteria; HIV Seropositivity; Humans; Microbial Sensitivity Tests; Zidovudine | 1997 |
Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors.
Topics: Adult; Anti-HIV Agents; Drug Resistance; Female; Germany; HIV Seropositivity; HIV-1; Humans; Male; Mutation; Zidovudine | 1997 |
A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.
Topics: Analysis of Variance; Anti-HIV Agents; Blood-Borne Pathogens; Case-Control Studies; Female; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Patient-to-Professional; Logistic Models; Male; Needlestick Injuries; Occupational Diseases; Population Surveillance; Risk Factors; Wounds, Stab; Zidovudine | 1997 |
Two-in-one tablet eases 'pill burden'.
Topics: Anti-HIV Agents; Drug Combinations; HIV Seropositivity; Humans; Lamivudine; Zidovudine | 1997 |
Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cohort Studies; Confidence Intervals; Female; France; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Multivariate Analysis; Odds Ratio; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Assessment; Zidovudine | 1997 |
Changes in CD8 cell subpopulations induced by antiretroviral therapy in human immunodeficiency virus infected patients.
Topics: Adult; Anti-HIV Agents; CD8-Positive T-Lymphocytes; Cell Count; Didanosine; Drug Therapy, Combination; Flow Cytometry; HIV Seropositivity; HIV-1; Humans; Male; Phenotype; RNA, Viral; Viremia; Zidovudine | 1997 |
Uveitis associated with human immunodeficiency virus infection.
Topics: Adult; Anti-HIV Agents; Aqueous Humor; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Eye Infections, Viral; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Practice Guidelines as Topic; Uveitis, Anterior; Uveitis, Posterior; Vitreous Body; Zidovudine | 1998 |
Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants.
Topics: Amino Acids; Anti-HIV Agents; Cells, Cultured; Codon; Drug Resistance, Microbial; Genes, Viral; Genetic Heterogeneity; Genetic Variation; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; Zidovudine | 1998 |
[Hepatic steatosis during treatment with zidovudine and lamivudine in an HIV-positive patient].
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Fatty Liver; HIV Seropositivity; Humans; Lamivudine; Male; Transaminases; Zidovudine | 1998 |
Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment.
Topics: Acidosis, Lactic; Adolescent; Anti-HIV Agents; Female; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Metabolic Clearance Rate; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Acute HIV syndrome after discontinuation of antiretroviral therapy in a patient treated before seroconversion.
Topics: Adult; Anti-HIV Agents; CD4-CD8 Ratio; Drug Therapy, Combination; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Male; Ritonavir; RNA, Viral; T-Lymphocytes, Cytotoxic; Zidovudine | 1998 |
Nonparametric estimation of covariance structure in longitudinal data.
Topics: Anti-HIV Agents; Bisexuality; Blood Pressure; CD4 Lymphocyte Count; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Infant, Newborn; Infant, Premature; Longitudinal Studies; Male; Models, Statistical; Multicenter Studies as Topic; Reproducibility of Results; Statistics, Nonparametric; Zidovudine | 1998 |
Increased cerebral blood volume in HIV-positive patients detected by functional MRI.
Topics: Adult; Anti-HIV Agents; Blood Volume; Cerebrovascular Circulation; Cognition Disorders; HIV Seropositivity; Humans; Magnetic Resonance Imaging; Middle Aged; Periaqueductal Gray; Reference Values; Zidovudine | 1998 |
Tumor necrosis factor beta and soluble APO-1/Fas independently predict progression to AIDS in HIV-seropositive patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; beta 2-Microglobulin; Biomarkers; Case-Control Studies; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; fas Receptor; Female; HIV Seropositivity; Humans; Lymphotoxin-alpha; Male; Predictive Value of Tests; Regression Analysis; Reverse Transcriptase Inhibitors; Solubility; Zidovudine | 1998 |
Antiviral therapy in a child with pediatric human immunodeficiency virus (HIV): case study of audiologic findings.
Topics: Anti-HIV Agents; Child; Evoked Potentials, Auditory, Brain Stem; Female; Hearing Loss, High-Frequency; Hearing Loss, Sensorineural; HIV Seropositivity; Humans; Photic Stimulation; Severity of Illness Index; Zidovudine | 1998 |
Proposed CD4(+) T-cell criteria for staging human immunodeficiency virus-infected Chinese adults.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cell Separation; China; Female; Flow Cytometry; HIV Seropositivity; Hong Kong; Humans; Longitudinal Studies; Male; Pneumonia, Pneumocystis; Survival Rate; Zidovudine | 1998 |
Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Seropositivity; Humans; Indinavir; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Male; Viral Load; Zidovudine | 1998 |
[Weak antiviral effect of changing two nucleoside analogues combined with antiretroviral agents. 3TC and d4T after ZDU and ddi or ddc].
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Retrospective Studies; Stavudine; Viral Load; Zalcitabine; Zidovudine | 1998 |
[Failure of anti-pneumococcal vaccination in a splenectomized patient with HIV infection].
Topics: Adult; Female; HIV Infections; HIV Seropositivity; Humans; Immunosuppression Therapy; Pneumococcal Infections; Splenectomy; Treatment Failure; Vaccination; Zidovudine | 1998 |
The interpretation of clinical trials of immediate versus delayed therapy.
Topics: Anti-HIV Agents; Biometry; Clinical Protocols; HIV Seropositivity; Humans; Life Tables; Models, Statistical; Prospective Studies; Randomized Controlled Trials as Topic; Survival Analysis; Zidovudine | 1998 |
[Clinical case of the month. Apropos of pancytopenia in a seropositive patient].
Topics: Adult; Anemia, Aplastic; Anti-HIV Agents; Bone Marrow; HIV Infections; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Male; Pancytopenia; Stavudine; Zidovudine | 1998 |
Recommendations for occupational exposures to HIV.
Topics: Anti-HIV Agents; Chemoprevention; Drug Monitoring; Follow-Up Studies; Health Personnel; HIV Antibodies; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Diseases; Occupational Exposure; Practice Guidelines as Topic; Risk Factors; Viral Load; Zidovudine | 1999 |
Severe paronychia due to zidovudine-induced neutropenia in a neonate.
Topics: Anti-HIV Agents; Follow-Up Studies; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Neutropenia; Paronychia; Zidovudine | 1999 |
Is the worst of the epidemic over? Back calculation of HIV seroprevalence in The Netherlands.
Topics: Acquired Immunodeficiency Syndrome; Disease Outbreaks; Health Policy; HIV Seropositivity; Humans; Models, Theoretical; Netherlands; Population Surveillance; Prevalence; Zidovudine | 1992 |
AIDS knowledge and attitudes for 1991. Data from the National Health Interview Survey.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Attitude to Health; Blood Donors; Condoms; Female; Health Knowledge, Attitudes, Practice; HIV Seropositivity; Humans; Interviews as Topic; Male; Middle Aged; United States; Zidovudine | 1993 |
Successful treatment of HIV-related vasculitis with peripheral neuropathy with short-term steroids followed by the association of zidovudine and plasmapheresis.
Topics: Adult; AIDS-Related Opportunistic Infections; Combined Modality Therapy; HIV Seropositivity; Humans; Male; Peripheral Nervous System Diseases; Plasmapheresis; Prednisone; Prospective Studies; Vasculitis; Zidovudine | 1993 |
Patient classification and cost analysis of AIDS and HIV: the case of Belgium.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Belgium; Cost of Illness; Drug Costs; Episode of Care; Female; Health Care Costs; HIV Infections; HIV Seropositivity; Hospital Costs; Hospitals, University; Humans; Male; Middle Aged; Zidovudine | 1997 |
Providing AZT in pregnancy--if not now then when?
Topics: Anti-HIV Agents; Female; Health Policy; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine | 1999 |
Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Counseling; Drug Resistance, Microbial; Drug Therapy; Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; North Carolina; Patient Compliance; Pregnancy; Zidovudine | 1999 |
[Dynamics of immunoglobulin production in non infected children born from HIV-1 infected mothers: effect of zidovudine].
Topics: Anti-HIV Agents; Antibody Formation; Female; HIV Seropositivity; Humans; Immunoglobulins; Infant; Infant Welfare; Infant, Newborn; Maternal Welfare; Pregnancy; Retrospective Studies; Zidovudine | 1999 |
Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals.
Topics: Base Sequence; Codon; Drug Resistance, Microbial; Genotype; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Molecular Sequence Data; Phylogeny; Zidovudine | 1999 |
Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group.
Topics: Anti-HIV Agents; Dacryocystorhinostomy; Drug Therapy, Combination; HIV Infections; HIV Seropositivity; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Male; Middle Aged; Needlestick Injuries; Occupational Exposure; Ophthalmology; Primary Prevention; Risk Factors; Zidovudine | 1999 |
Denying effective antiretroviral drugs to HIV-positive pregnant women--the national government's flawed decision.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Drug Costs; Female; Health Policy; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Zidovudine | 1999 |
Bleeding episodes in HIV-positive patients taking HIV protease inhibitors: a case series.
Topics: Adolescent; Adult; Aged; Databases, Factual; Female; Hemophilia A; Hemorrhage; HIV Protease Inhibitors; HIV Seropositivity; Humans; Indinavir; Male; Middle Aged; Nelfinavir; Saquinavir; Treatment Outcome; United States; United States Food and Drug Administration; Zidovudine | 1999 |
The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination.
Topics: Adult; Antiviral Agents; Female; HIV Infections; HIV Seropositivity; Humans; Indinavir; Insemination, Artificial, Heterologous; Lamivudine; Male; Pregnancy; Tissue Donors; Zidovudine | 1999 |
Predictors of optimal virological response to potent antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; HIV Protease Inhibitors; HIV Seropositivity; Humans; Lamivudine; Male; Nelfinavir; Outcome Assessment, Health Care; Predictive Value of Tests; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Zidovudine | 1999 |
Investigations of possible failures of postexposure prophylaxis following occupational exposures to human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; False Negative Reactions; False Positive Reactions; Female; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Male; Occupational Exposure; Practice Guidelines as Topic; Public Health; United States; Zidovudine | 1999 |
[Pustulous psoriasis resistant to conventional treatment].
Topics: Adult; Antiviral Agents; Drug Resistance; Drug Therapy, Combination; HIV Seropositivity; Humans; Lamivudine; Male; Psoriasis; Saquinavir; Zidovudine | 1999 |
Secondary mania in patients with HIV infection: are antiretrovirals protective?
Topics: Adult; Anti-HIV Agents; Atrophy; Bipolar Disorder; Brain; Case-Control Studies; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Seropositivity; Humans; Magnetic Resonance Imaging; Male; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Zidovudine | 1999 |
Advanced Hodgkin's disease in a pregnant HIV seropositive woman: favorable mother and baby outcome following combined anticancer and antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; HIV Seropositivity; Hodgkin Disease; Humans; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Remission Induction; Stavudine; Zidovudine | 2000 |
Thiamin deficiency in HIV-positive patients: evaluation by erythrocyte transketolase activity and thiamin pyrophosphate effect.
Topics: Adult; Anti-HIV Agents; Body Mass Index; Case-Control Studies; CD4 Lymphocyte Count; Female; HIV Seropositivity; Humans; Male; Middle Aged; Nutritional Status; Thiamine Deficiency; Thiamine Pyrophosphate; Transketolase; Zidovudine | 1999 |
AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV seropositive patients in São Paulo, Brazil.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Distribution; Aged; AIDS-Related Opportunistic Infections; Antiviral Agents; Brazil; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; HIV Seropositivity; Hospitals, University; Humans; Incidence; Male; Middle Aged; Pneumonia, Pneumocystis; Risk-Taking; Sex Distribution; Survival Rate; Tuberculosis; Zidovudine | 1999 |
Decreased HIV-associated T cell apoptosis by HIV protease inhibitors.
Topics: Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Didanosine; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Jurkat Cells; Nelfinavir; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; T-Lymphocytes; Viral Load; Zidovudine | 2000 |
Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Anti-HIV Agents; CD4 Lymphocyte Count; Female; Heterosexuality; HIV Infections; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; London; Male; Population Surveillance; Retrospective Studies; Risk Factors; Sex Factors; Substance Abuse, Intravenous; Survival Analysis; Zidovudine | 2000 |
Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Blood Component Transfusion; CD4 Lymphocyte Count; Cohort Studies; Cytomegalovirus Infections; Disease Progression; Follow-Up Studies; Hemophilia A; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; RNA, Viral; Time Factors; Zidovudine | 2000 |
Flirting with strange ideas. Mbeki reaches out to a controversial AIDS researcher.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Biochemistry; Clinical Trials as Topic; Famous Persons; Female; History, 20th Century; HIV Seropositivity; Humans; Insecticides; Male; Nevirapine; Organic Chemicals; Pregnancy; Research; Reverse Transcriptase Inhibitors; San Francisco; South Africa; United States; Zidovudine | 2000 |
Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Female; Gestational Age; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Retrospective Studies; Risk Factors; Zidovudine | 2000 |
[Cost effectiveness analysis of highly active antiretroviral therapy in HIV asymptomatic patients].
Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Didanosine; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nevirapine; Sickness Impact Profile; Spain; Stavudine; Viral Load; Zidovudine | 2000 |
A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215.
Topics: Anti-HIV Agents; Codon; Didanosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Genotype; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nucleic Acid Hybridization; Point Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zalcitabine; Zidovudine | 2000 |
Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers.
Topics: Adult; Animals; Anti-HIV Agents; DNA; Female; Fetal Blood; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Leukocytes; Maternal-Fetal Exchange; Mice; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2000 |
Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.
Topics: Anti-HIV Agents; Codon; Drug Resistance, Microbial; Genotype; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Lamivudine; Mutation; Polymorphism, Genetic; Prevalence; Reverse Transcriptase Inhibitors; Spain; Zidovudine | 2001 |
Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study.
Topics: Adolescent; Adult; Aged; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Disease Progression; Female; Hemoglobins; HIV Infections; HIV Seropositivity; HIV-1; Humans; Middle Aged; Multivariate Analysis; Odds Ratio; Prevalence; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2001 |
Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid.
Topics: Drug Resistance, Microbial; Drug Resistance, Multiple; Genotype; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Mutation; Phenotype; Protease Inhibitors; Reverse Transcriptase Inhibitors; Spain; Viral Load; Zidovudine | 2001 |
Prenatal short-course zidovudine reduces mortality in children born to human immunodeficiency virus-positive mothers in rural Kenya.
Topics: Anti-HIV Agents; Child; Child, Preschool; Female; HIV Seropositivity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Rural Health; Treatment Outcome; Zidovudine | 2001 |
Safety and activity of zalcitabine and zidovudine combination in HIV-positive people with CD4 cell counts < or = 300 cells/mm3. The Roche M50002 Study Group.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Male; Middle Aged; Zalcitabine; Zidovudine | 1996 |
Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Biomarkers; CD4 Lymphocyte Count; HIV Core Protein p24; HIV Seropositivity; Humans; RNA, Viral; Zidovudine | 1997 |
Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Seropositivity; Humans; RNA, Viral; Zalcitabine; Zidovudine | 1997 |
Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women.
Topics: Anti-HIV Agents; Case-Control Studies; Cesarean Section; Female; Fever; HIV Seropositivity; Humans; Incidence; Odds Ratio; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 2001 |
Low-dose, sublingual AZT-monophosphate therapy for HIV+ patients?
Topics: Administration, Sublingual; Anti-HIV Agents; Dideoxynucleotides; HIV; HIV Infections; HIV Seropositivity; Humans; Models, Biological; Thymidine Kinase; Thymine Nucleotides; Virus Replication; Zidovudine | 2001 |
Trial data available.
Topics: Didanosine; HIV Seropositivity; Humans; Zidovudine | 1995 |
Acute decrease in HIV-1 viral load after initiation of zidovudine therapy: implications for interrupting vertical transmission.
Topics: CD4 Lymphocyte Count; HIV Core Protein p24; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; RNA, Viral; Time Factors; Viremia; Zidovudine | 1995 |
Long-acting AZT accompanied by less resistance and fewer side effects.
Topics: Anti-HIV Agents; Delayed-Action Preparations; Drug Resistance, Microbial; HIV Seropositivity; Humans; Zidovudine | 1996 |
Inmate not entitled to choose his own course of HIV medicines.
Topics: Acyclovir; Didanosine; Drug Therapy, Combination; HIV Seropositivity; Humans; Informed Consent; Male; New York; Patient Participation; Prisoners; Refusal to Treat; Zidovudine | 1995 |
Potent new AIDS drugs underscore promise of combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Drug Approval; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; Humans; Isoquinolines; Lamivudine; Quinolines; Saquinavir; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1996 |
CDC wants more input before updating post-exposure guidelines. Centers for Disease Control and Prevention.
Topics: Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Guidelines as Topic; Health Personnel; HIV Infections; HIV Seropositivity; Infectious Disease Transmission, Patient-to-Professional; Insurance Benefits; Needlestick Injuries; Occupational Exposure; United States; Zidovudine | 1996 |
[A rare etiology of hepatic steatosis associated with lactic acidosis: the toxicity of antiviral nucleoside analogues].
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Antimetabolites; Didanosine; Fatal Outcome; Fatty Liver; Female; HIV Seropositivity; Humans; Lamivudine; Microscopy, Electron; Mitochondria, Liver; Stavudine; Zidovudine | 2001 |
Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cell Count; Colony-Forming Units Assay; Cytokines; Erythrocyte Count; Female; Fetal Blood; Flow Cytometry; Hematopoietic Stem Cells; HIV Seronegativity; HIV Seropositivity; Humans; Infant, Newborn; Interferon-gamma; Interleukin-2; Interleukin-4; Maternal-Fetal Exchange; Organ Culture Techniques; Pregnancy; Thymus Gland; Zidovudine | 2001 |
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART.
Topics: Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Disease Progression; Female; Hepatitis B Surface Antigens; Hepatitis C; HIV Seropositivity; HIV-1; Humans; Male; Proportional Hazards Models; Stavudine; Zidovudine | 2001 |
US journal attacks unethical HIV trials.
Topics: Africa; Asia; Developing Countries; Economics; Editorial Policies; HIV Seropositivity; Human Experimentation; Humans; Latin America; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Public Policy; Publishing; Research Design; United States; Zidovudine | 1997 |
AIDS study casts doubt on value of hastened drug approval in U.S.
Topics: Acquired Immunodeficiency Syndrome; Drugs, Investigational; Europe; Evaluation Studies as Topic; Federal Government; Government; Government Regulation; HIV Seropositivity; Human Experimentation; Humans; Methods; Pharmaceutical Preparations; Research; Risk; Risk Assessment; Social Control, Formal; Therapeutic Human Experimentation; United States; Zidovudine | 1993 |
New York AIDS panel encourages doctors to test pregnant women.
Topics: Advisory Committees; AIDS Serodiagnosis; Coercion; Counseling; HIV Seropositivity; Humans; Infant, Newborn; Informed Consent; Mandatory Programs; New York; Patient Care; Pharmaceutical Preparations; Physicians; Pregnancy; Pregnant Women; Privacy; Public Policy; Voluntary Programs; Zidovudine | 1994 |
Discovery that AIDS can be prevented in babies raises debate on mandatory testing.
Topics: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; Attitude; Confidentiality; Control Groups; Ethicists; Ethics; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; Mandatory Testing; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Preventive Medicine; Research Design; Voluntary Programs; Zidovudine | 1994 |
AIDS studies violate Helsinki rights accord.
Topics: Centers for Disease Control and Prevention, U.S.; Codes of Ethics; Developing Countries; Economics; Ethical Relativism; Ethics; Ethics, Professional; Federal Government; Financial Support; Government; Guidelines as Topic; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; International Cooperation; Internationality; National Institutes of Health (U.S.); Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Preventive Medicine; Research; Research Design; Scientific Misconduct; Therapeutic Human Experimentation; United States; Zidovudine | 1997 |
A look at ethics and AIDS -- We're trying to help our sickest people, not exploit them In the researcher's code of conduct, contradictions abound.
Topics: Acquired Immunodeficiency Syndrome; Codes of Ethics; Control Groups; Developing Countries; Ethical Relativism; Ethics; Ethics, Professional; HIV Seropositivity; Human Experimentation; Humans; Informed Consent; International Cooperation; Internationality; Nontherapeutic Human Experimentation; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Research Design; Research Personnel; Risk; Risk Assessment; Socioeconomic Factors; Uganda; Vulnerable Populations; Withholding Treatment; World Health Organization; Zidovudine | 1997 |
AIDS research in Africa: juggling risks and hopes.
Topics: Africa; Attitude; Centers for Disease Control and Prevention, U.S.; Cognition; Comprehension; Cote d'Ivoire; Developing Countries; Dominican Republic; Economics; Ethical Relativism; Ethical Review; Ethics; Federal Government; Financial Support; Government; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; Informed Consent; National Institutes of Health (U.S.); Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Preventive Medicine; Research; Research Design; Research Personnel; Scientific Misconduct; Thailand; Therapeutic Human Experimentation; United States; Zidovudine | 1997 |
Shades of Tuskegee.
Topics: Africa; Black or African American; Black People; Cost-Benefit Analysis; Developing Countries; Economics; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; International Cooperation; Internationality; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Public Policy; Random Allocation; Research Design; Scientific Misconduct; Syphilis; United States; Withholding Treatment; Zidovudine | 1997 |
Top U.S. health officials defend third-world H.I.V. research.
Topics: Centers for Disease Control and Prevention, U.S.; Codes of Ethics; Developing Countries; Economics; Ethical Relativism; Ethics; Ethics, Professional; Federal Government; Financial Support; Government; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; Informed Consent; International Cooperation; Internationality; National Institutes of Health (U.S.); Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Preventive Medicine; Research; Research Design; Scientific Misconduct; Therapeutic Human Experimentation; United States; Zidovudine | 1997 |
U.S. AIDS research in poor nations raises outcry on ethics.
Topics: Acquired Immunodeficiency Syndrome; Africa; Centers for Disease Control and Prevention, U.S.; Control Groups; Developing Countries; Dominican Republic; Fetus; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; International Cooperation; Internationality; National Institutes of Health (U.S.); Nontherapeutic Human Experimentation; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Reference Standards; Research Design; Research Personnel; Socioeconomic Factors; Thailand; United States; Vulnerable Populations; Zidovudine | 1997 |
AIDS experts leave journal after studies are criticized.
Topics: Developing Countries; Disclosure; Editorial Policies; Federal Government; Financing, Government; Government; HIV Seropositivity; Human Experimentation; Humans; Immunization; International Cooperation; Internationality; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Publishing; Research Design; Research Personnel; Scientific Misconduct; United States; Zidovudine | 1997 |
Panel urges H.I.V. tests for all pregnant women.
Topics: Advisory Committees; AIDS Serodiagnosis; Cost-Benefit Analysis; Counseling; HIV Seropositivity; Humans; Infant, Newborn; Mandatory Testing; National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; Patient Care; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Preventive Medicine; Public Policy; United States; Zidovudine | 1998 |
Placebo use is suspended in overseas AIDS trials.
Topics: Acquired Immunodeficiency Syndrome; Centers for Disease Control and Prevention, U.S.; Developing Countries; Economics; Federal Government; Government; HIV Seropositivity; Human Experimentation; Humans; International Cooperation; Internationality; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Public Policy; Research; Research Design; Therapeutic Human Experimentation; United States; Zidovudine | 1998 |
Prohibiting AIDS testing in the health insurance context: patching up a patchwork system.
Topics: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; Catholicism; Coercion; Confidentiality; Cost-Benefit Analysis; Counseling; Delivery of Health Care; Drug Industry; Duty to Warn; Economics; Financial Support; Goals; Government Regulation; Health Facilities; HIV Seropositivity; Homosexuality; Human Rights; Humans; Industry; Insurance, Health; Mandatory Programs; Mass Screening; Men; Moral Obligations; Pharmaceutical Preparations; Prejudice; Public Policy; Social Change; Social Control, Formal; Social Justice; Social Responsibility; Social Values; United States; Zidovudine | 1990 |
Women in clinical trials: HIV-infected women.
Topics: Female; HIV Seropositivity; Human Experimentation; Humans; Minority Groups; Patient Selection; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Research Subjects; Risk; Risk Assessment; United States; Women; Zidovudine | 1993 |
Stigma, conflict, and the approval of AIDS drugs.
Topics: Acquired Immunodeficiency Syndrome; Community Participation; Drugs, Investigational; Federal Government; Freedom; Government; Government Regulation; Health Care Rationing; HIV Seropositivity; Homosexuality; Human Experimentation; Humans; Patient Care; Personal Autonomy; Pharmaceutical Preparations; Politics; Prejudice; Public Policy; Resource Allocation; Risk; Risk Assessment; Social Change; Social Control, Formal; Stereotyping; Terminally Ill; United States; United States Food and Drug Administration; Violence; Zidovudine | 1995 |
The scarlet letter "A": AIDS in a computer society.
Topics: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; Civil Rights; Computers; Confidentiality; Contact Tracing; Databases, Factual; Duty to Warn; Economics; Education; Employment; Epidemiology; Federal Government; Government; Government Regulation; HIV Seropositivity; Humans; Information Dissemination; Information Services; Insurance; Jurisprudence; Liability, Legal; Patient Access to Records; Patient Advocacy; Patient Care; Patient Rights; Pharmaceutical Preparations; Physicians; Privacy; Public Health; Public Opinion; Refusal to Treat; Risk; Risk Assessment; Social Control, Formal; State Government; Stereotyping; Stress, Psychological; United States; Zidovudine | 1990 |
AIDS: patient power puts research on trial.
Topics: Acquired Immunodeficiency Syndrome; Attitude; HIV Seropositivity; Human Experimentation; Humans; Patient Care; Patient Compliance; Patient Selection; Patients; Pharmaceutical Preparations; Placebos; Random Allocation; Research; Research Design; Research Subjects; Therapeutic Human Experimentation; United Kingdom; United States; Zidovudine | 1988 |
It's for (y)our own good: an analysis of the discourses surrounding mandatory, unblinded HIV testing of newborns.
Topics: Abortion, Induced; Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; Biomedical Research; Black or African American; Cesarean Section; Child; Coercion; Contraception; Counseling; Decision Making; Delivery of Health Care; Female; Fetus; Health Education; Hispanic or Latino; HIV Seropositivity; Human Rights; Humans; Infant, Newborn; Life Style; Mandatory Testing; Mothers; Pharmaceutical Preparations; Poverty; Pregnancy; Pregnant Women; Prejudice; Prevalence; Preventive Medicine; Privacy; Quality of Health Care; Reproduction; Research; Sexuality; Socioeconomic Factors; Stereotyping; Sterilization, Reproductive; Substance-Related Disorders; United States; Women; Women's Health; Women's Rights; Zidovudine | 1998 |
Trial and error: can good science be bad medicine?
Topics: Africa; Asia; Centers for Disease Control and Prevention, U.S.; Developing Countries; Federal Government; Financing, Government; Government; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; International Cooperation; Internationality; National Institutes of Health (U.S.); Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Random Allocation; Research; Research Design; Therapeutic Human Experimentation; United States; Zidovudine | 1998 |
The ethics of HIV research in developing nations.
Topics: Acquired Immunodeficiency Syndrome; Africa; Altruism; Beneficence; Centers for Disease Control and Prevention, U.S.; Codes of Ethics; Control Groups; Developing Countries; Dominican Republic; Ethical Relativism; Ethical Theory; Ethics; Ethics, Professional; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; Informed Consent; International Cooperation; Internationality; National Institutes of Health (U.S.); Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Preventive Medicine; Random Allocation; Reference Standards; Research; Research Design; Research Subjects; Social Justice; Socioeconomic Factors; Thailand; Therapeutic Human Experimentation; World Health Organization; Zidovudine | 1998 |
Ethics of placebo-controlled trials in developing countries.
Topics: Acquired Immunodeficiency Syndrome; Control Groups; Developing Countries; Economics; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; International Cooperation; Internationality; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Preventive Medicine; Random Allocation; Research Design; Thailand; Zidovudine | 1998 |
Unethical perinatal HIV transmission trials establish bad precedent.
Topics: Acquired Immunodeficiency Syndrome; Africa; Asia; Complementary Therapies; Control Groups; Cost-Benefit Analysis; Delivery of Health Care; Developing Countries; Drug Industry; Economics; Ethical Analysis; Ethical Review; Ethics; Guidelines as Topic; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; Informed Consent; International Cooperation; Internationality; Latin America; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Preventive Medicine; Research; Research Design; Research Subjects; Therapeutic Human Experimentation; Western World; Zidovudine | 1998 |
Ethical challenges of HIV clinical trials in developing countries.
Topics: Acquired Immunodeficiency Syndrome; Altruism; Beneficence; Complementary Therapies; Conflict of Interest; Control Groups; Developing Countries; Drug Industry; Economics; Ethical Review; Ethics; Freedom; Guidelines as Topic; HIV Seropositivity; Human Experimentation; Human Rights; Humans; Infant, Newborn; International Cooperation; Internationality; National Institutes of Health (U.S.); Personal Autonomy; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Preventive Medicine; Public Policy; Reference Standards; Research; Research Design; Research Personnel; Research Subjects; Social Justice; Therapeutic Human Experimentation; United States; Zidovudine | 1998 |
Is ethical research feasible in developed and developing countries?
Topics: Acquired Immunodeficiency Syndrome; Advisory Committees; Community Participation; Control Groups; Delivery of Health Care; Developing Countries; Economics; Ethics; Guidelines as Topic; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; Informed Consent; International Cooperation; Internationality; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Preventive Medicine; Public Policy; Research; Research Design; Research Subjects; Therapeutic Human Experimentation; Western World; World Health Organization; Zidovudine | 1998 |
Replies to commentaries.
Topics: Acquired Immunodeficiency Syndrome; Delivery of Health Care; Developing Countries; Drug Industry; Ethics; Financial Support; Financing, Government; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; International Cooperation; Internationality; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Preventive Medicine; Public Policy; Research; Research Design; Social Justice; Socioeconomic Factors; Therapeutic Human Experimentation; Zidovudine | 1998 |
Access to AIDS treatment in developing countries: a global issue of equity and human rights.
Topics: Acquired Immunodeficiency Syndrome; Asia; Biomedical Technology; Developing Countries; Drug Industry; HIV Seropositivity; Human Experimentation; Human Rights; Humans; International Cooperation; Internationality; Pharmaceutical Preparations; Placebos; Politics; Pregnancy; Pregnant Women; Public Policy; Social Justice; Socioeconomic Factors; Technology Transfer; Zidovudine | 1998 |
The need for improved access to experimental drug therapy: AIDS activists and their call for a parallel track policy.
Topics: Acquired Immunodeficiency Syndrome; Community Participation; Decision Making; Drug Industry; Drugs, Investigational; Federal Government; Government; Government Regulation; Health Care Rationing; HIV Seropositivity; Human Experimentation; Humans; Informed Consent; Patient Care; Patient Participation; Patient Selection; Patients; Pharmaceutical Preparations; Placebos; Politics; Poverty; Public Policy; Random Allocation; Reference Standards; Research; Research Design; Research Subjects; Risk; Risk Assessment; Social Control, Formal; Terminally Ill; Therapeutic Human Experimentation; United States; United States Food and Drug Administration; Zidovudine | 1991 |
Unblinded mandatory HIV screening of newborns: care or coercion?
Topics: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; Anonymous Testing; Behavior; Behavior Control; Civil Rights; Coercion; Confidentiality; Counseling; Disclosure; Fathers; Female; Freedom; HIV Seropositivity; Humans; Infant, Newborn; Informed Consent; Jurisprudence; Legislation as Topic; Mandatory Reporting; Mandatory Testing; Mass Screening; Mothers; New York; Personal Autonomy; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Prejudice; Prevalence; Preventive Medicine; Privacy; Public Health; Risk; Risk Assessment; Socioeconomic Factors; State Government; United States; Voluntary Programs; Vulnerable Populations; Women; Women's Health Services; Zidovudine | 1994 |
What would you do?: an investigation into Jewish biomedical ethics.
Topics: Abortion, Eugenic; Abortion, Therapeutic; AIDS Serodiagnosis; Bioethical Issues; Bioethics; Coercion; Confidentiality; Cystic Fibrosis; Decision Making; Disclosure; Embryo Transfer; Embryo, Mammalian; Fathers; Fertilization in Vitro; Fetal Viability; Fetus; Freedom; Genetic Counseling; Genetic Predisposition to Disease; Genetic Privacy; Genetic Testing; HIV Seropositivity; Humans; Incidental Findings; Infant, Newborn; Insurance Selection Bias; Insurance, Life; Judaism; Mandatory Testing; Marriage; Maternal Welfare; Mothers; Neoplasms; Parent-Child Relations; Patient Care; Pedigree; Personal Autonomy; Pharmaceutical Preparations; Pregnancy; Pregnancy, Multiple; Pregnant Women; Prejudice; Sex Determination Analysis; Treatment Refusal; Zidovudine | 1995 |
Newborn HIV screening and New York Assembly Bill No. 6747-B: privacy and equal protection of pregnant women.
Topics: AIDS Serodiagnosis; Anonymous Testing; Child; Civil Rights; Community Participation; Confidentiality; Counseling; Disclosure; Epidemiology; Freedom; HIV Seropositivity; Humans; Infant, Newborn; Jurisprudence; Legislation as Topic; Life Support Care; Mandatory Testing; Minority Groups; Mothers; New York; Patient Care; Personal Autonomy; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Prejudice; Prenatal Diagnosis; Prevalence; Privacy; Probability; Quality of Life; Risk; Risk Assessment; Uncertainty; Voluntary Programs; Zidovudine | 1994 |
Where ignorance is not bliss: a proposal for mandatory HIV testing of pregnant women.
Topics: Abortion, Eugenic; AIDS Serodiagnosis; Centers for Disease Control and Prevention, U.S.; Coercion; Communicable Diseases; Counseling; Decision Making; Disclosure; Employment; Federal Government; Female; Fetus; Freedom; Government; Guidelines as Topic; HIV Seropositivity; Humans; Infant, Newborn; Insurance, Health; Jurisprudence; Mandatory Testing; Mass Screening; Patient Care; Patient Participation; Personal Autonomy; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Prejudice; Preventive Medicine; Risk; Risk Assessment; State Government; Stereotyping; Treatment Refusal; United States; Voluntary Programs; Women's Rights; Zidovudine | 1996 |
Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women.
Topics: Adolescent; Adult; Age Factors; Aged; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cohort Studies; Education; Female; HIV Protease Inhibitors; HIV Seropositivity; Humans; Logistic Models; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Zidovudine | 2002 |
The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects.
Topics: Adolescent; Adult; Anti-HIV Agents; Drug Combinations; Female; HIV Seropositivity; Humans; Lamivudine; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Zidovudine | 2002 |
HIV, women, and access to clinical trials: tort liability and lessons from DES.
Topics: Clinical Trials as Topic; Diethylstilbestrol; Disclosure; Drug-Related Side Effects and Adverse Reactions; Federal Government; Female; Government; Government Regulation; Hazardous Substances; HIV Seropositivity; Human Experimentation; Humans; Informed Consent; Jurisprudence; Liability, Legal; Malpractice; Occupational Exposure; Patient Selection; Pregnancy; Pregnant Women; Prejudice; Radiation; Research Subjects; Risk; Risk Assessment; Social Control, Formal; United States; Women; Women's Health; Wounds and Injuries; Zidovudine | 1998 |
The case against mandatory HIV testing of pregnant women: the legal and public policy implications.
Topics: AIDS Serodiagnosis; Civil Rights; Coercion; Cost-Benefit Analysis; Counseling; Domestic Violence; HIV Seropositivity; Humans; Infant, Newborn; Jurisprudence; Mandatory Testing; Patient Compliance; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Privacy; Public Policy; Risk; Risk Assessment; Stereotyping; United States; Voluntary Programs; Zidovudine | 1998 |
AZT price cut for Third World mothers-to-be.
Topics: Developing Countries; Drug Industry; Economics; HIV Seropositivity; Human Experimentation; Humans; Infant, Newborn; Patient Care; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Research Design; Zidovudine | 1998 |
[Vesiculo-pustular cutaneous eruption disclosing primary infection by HIV virus].
Topics: Adult; Female; HIV Infections; HIV Seropositivity; Humans; Skin Diseases, Vesiculobullous; Zidovudine | 1992 |
Zidovudine and cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Cytomegalovirus Infections; Eye Infections, Viral; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; HIV Seropositivity; Humans; Male; Retinitis; Visual Acuity; Zidovudine | 1992 |
Antiretroviral therapy with association alpha-interferon + AZT in HIV-positive subjects. Preliminary report of an ongoing clinical trial. The Infectivologists HIV/Interferon Study Group.
Topics: HIV Seropositivity; Humans; Interferon Type I; Recombinant Proteins; Retroviridae Infections; Virus Replication; Zidovudine | 1992 |
In-vitro activity of zidovudine against mycoplasma.
Topics: HIV Seropositivity; Humans; In Vitro Techniques; Mycoplasma; Mycoplasma fermentans; Zidovudine | 1992 |
HIV-1 sensitivity to zidovudine and clinical outcome.
Topics: Adult; Cells, Cultured; Child; Drug Resistance, Microbial; HIV Infections; HIV Seropositivity; Humans; T-Lymphocytes; Zidovudine | 1992 |
Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
Topics: Adult; CD4-Positive T-Lymphocytes; Cohort Studies; Follow-Up Studies; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; Middle Aged; Multivariate Analysis; Substance Abuse, Intravenous; T-Lymphocyte Subsets; Zidovudine | 1992 |
Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen.
Topics: CD4-Positive T-Lymphocytes; Cross-Sectional Studies; HIV Infections; HIV Seropositivity; HIV-1; Leukocyte Count; Leukocytosis; Longitudinal Studies; Prevalence; Risk Factors; Semen; Zidovudine | 1992 |
Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children.
Topics: Acquired Immunodeficiency Syndrome; Child, Preschool; Cohort Studies; Confidence Intervals; Female; HIV Seropositivity; Humans; Infant; Infant, Newborn; Italy; Male; Odds Ratio; Opportunistic Infections; Prospective Studies; Risk; Survival Analysis; Zidovudine | 1992 |
The relationship of HIV-1 viral sequences detected by the polymerase chain reaction in haemophilic patients to clinical and other markers of infection.
Topics: Adult; Aged; Base Sequence; beta 2-Microglobulin; Biomarkers; CD4-Positive T-Lymphocytes; Child; Enzyme-Linked Immunosorbent Assay; Hemophilia A; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; Male; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Predictive Value of Tests; Zidovudine | 1992 |
CD4 lymphocyte count as an indicator of delay in seeking human immunodeficiency virus-related treatment.
Topics: Adult; CD4-Positive T-Lymphocytes; Female; Health Behavior; HIV Infections; HIV Seropositivity; Humans; Insurance, Health; Leukocyte Count; Male; Pneumonia, Pneumocystis; Retrospective Studies; Zidovudine | 1992 |
Immunodeficiency and the risk of death in HIV infection.
Topics: Cause of Death; CD4-Positive T-Lymphocytes; Cohort Studies; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; Risk; Time Factors; Zidovudine | 1992 |
Virus neutralizing antibodies at different stages of the HIV disease: increased levels after azidothymidine treatment.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; HIV Antibodies; HIV Infections; HIV Seropositivity; Humans; Neutralization Tests; Prospective Studies; Zidovudine | 1992 |
Survival and disease progression in human immunodeficiency virus-infected women after an index delivery.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; AIDS-Related Opportunistic Infections; Candidiasis, Oral; CD4-Positive T-Lymphocytes; Female; HIV Seropositivity; Humans; Leukocyte Count; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Survival Rate; Zidovudine | 1992 |
Detection of circulating p24 antigen-positive CD4+ cells during HIV infection by flow cytometry.
Topics: Blood Circulation; CD4-Positive T-Lymphocytes; Flow Cytometry; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Time Factors; Treatment Outcome; Zidovudine | 1992 |
Trends in zidovudine prescription since 1987 in AIDS-free HIV-positive French patients attending university hospitals.
Topics: CD4-Positive T-Lymphocytes; France; HIV Seropositivity; Hospitals, University; Humans; Leukocyte Count; Time Factors; Zidovudine | 1992 |
Salmonella, Campylobacter and Shigella in HIV-seropositive patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Campylobacter Infections; CD4-Positive T-Lymphocytes; Ciprofloxacin; Dysentery, Bacillary; Feces; HIV Seropositivity; Humans; Leukocyte Count; Male; Middle Aged; Pneumonia, Pneumocystis; Recurrence; Retrospective Studies; Salmonella Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1992 |
Providing early intervention care to the newly diagnosed adult HIV positive patient.
Topics: Adult; AIDS-Related Opportunistic Infections; HIV Seropositivity; Humans; Patient Care Planning; Zidovudine | 1992 |
Acidification modified p24 antigen capture assay in HIV seropositives.
Topics: Analysis of Variance; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Hydrogen-Ion Concentration; Prognosis; Zidovudine | 1992 |
Exposure to blood borne infections in health care workers.
Topics: Blood; Body Fluids; Hepatitis B; HIV Infections; HIV Seropositivity; Housekeeping, Hospital; Humans; Immunization, Passive; Immunoglobulins; Infection Control; Medical Staff, Hospital; Needlestick Injuries; Nursing Staff, Hospital; Occupational Diseases; Occupational Exposure; Personnel, Hospital; Universal Precautions; Western Australia; Zidovudine | 1992 |
[Progression to AIDS among HIV-seropositive hemophiliacs].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Age Factors; CD4-CD8 Ratio; Child; Child, Preschool; Cohort Studies; Follow-Up Studies; Hemophilia A; HIV Seropositivity; Humans; Incidence; Life Tables; Male; Opportunistic Infections; Zidovudine | 1992 |
[HIV infection. Natural history, classification, treatment and occupational risk].
Topics: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; HIV Infections; HIV Seropositivity; Humans; Occupational Diseases; Risk Factors; Zidovudine | 1992 |
Use of zidovudine following occupational exposure to human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; False Negative Reactions; HIV Seropositivity; Humans; Needlestick Injuries; Occupational Exposure; Zidovudine | 1992 |
Zidovudine overdose in an asymptomatic HIV seropositive patient with hemophilia.
Topics: Blood Chemical Analysis; Drug Overdose; Hemophilia A; HIV Seropositivity; Hospitalization; Humans; Length of Stay; Male; Radioimmunoassay; Zidovudine | 1992 |
Performance of patients with early HIV-1 infection on the Stroop Task.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Anxiety; Cognition; Color Perception; HIV Seropositivity; HIV-1; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Reaction Time; Zidovudine | 1992 |
Quantitative RNA and DNA gene amplification can rapidly monitor HIV infection and antiviral activity in cell cultures.
Topics: Cells, Cultured; DNA, Viral; Genes, gag; HIV; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; RNA, Viral; Virus Replication; Zidovudine | 1992 |
Physical conditioning among HIV-positive men.
Topics: Exercise; HIV Seropositivity; Humans; Male; Zidovudine | 1992 |
HIV detection in culture of peripheral blood mononuclear cells: a relevant in vitro correlate of the antiviral effect of ZDV in vivo.
Topics: Cells, Cultured; Female; HIV; HIV Seropositivity; Humans; Leukocytes, Mononuclear; Male; Virus Replication; Zidovudine | 1992 |
Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Analysis of Variance; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lung; Male; Opportunistic Infections; Pneumonia, Pneumocystis; Prospective Studies; Pulmonary Diffusing Capacity; Smoking; Time Factors; Zidovudine | 1992 |
Quantitation of human immunodeficiency virus (HIV) with respect to disease stage and zidovudine (AZT) therapy.
Topics: Cells, Cultured; Female; HIV Core Protein p24; HIV Infections; HIV Seropositivity; HIV-1; Humans; Leukocytes, Mononuclear; Male; Viremia; Zidovudine | 1992 |
HIV infection--10 years on.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Attitude to Health; Child; Child, Preschool; Developing Countries; Female; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Risk-Taking; Socioeconomic Factors; Zidovudine | 1992 |
Bilateral optic neuropathies with remission in two HIV-positive men.
Topics: Adult; HIV Infections; HIV Seropositivity; Humans; Male; Optic Nerve Diseases; Prednisone; Prognosis; Remission Induction; Zidovudine | 1992 |
Neurological and neuropsychological performance in HIV seropositive men without symptoms.
Topics: Age Factors; AIDS Dementia Complex; Bisexuality; Cognition Disorders; Cross-Sectional Studies; Evoked Potentials, Auditory, Brain Stem; HIV Seropositivity; Homosexuality; Humans; Magnetic Resonance Imaging; Male; Neurologic Examination; Neuropsychological Tests; Prevalence; Zidovudine | 1992 |
[What attitude to take in symptomless HIV infection?].
Topics: CD4 Antigens; HIV Seropositivity; Humans; Lymphocytes; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Zidovudine | 1992 |
New zidovudine trial and ethnic origins of HIV positive women.
Topics: Africa; Female; HIV Seropositivity; Humans; London; Male; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1992 |
Wasted drugs in HIV infections and AIDS.
Topics: HIV Infections; HIV Seropositivity; Humans; Patient Compliance; Zidovudine | 1992 |
Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Adult; Dialysis Solutions; HIV Seropositivity; Humans; Kidney Diseases; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Reproducibility of Results; Zidovudine | 1992 |
Improvement of motor performance of HIV-positive patients under AZT therapy.
Topics: HIV Seropositivity; Humans; Leukocyte Count; Movement; Muscle Contraction; Neuropsychological Tests; Reaction Time; T-Lymphocytes; Zidovudine | 1992 |
Assessment of the pharmacy service needs of HIV-positive outpatients receiving zidovudine.
Topics: Adolescent; Adult; Ambulatory Care; Confidentiality; Health Services Needs and Demand; HIV Seropositivity; Hospital Bed Capacity, 300 to 499; Humans; Male; Ontario; Patient Education as Topic; Patient Satisfaction; Pharmaceutical Services; Risk Factors; Surveys and Questionnaires; Zidovudine | 1992 |
[Repeat estimate of the number of HIV-seropositive subjects in The Netherlands].
Topics: Acquired Immunodeficiency Syndrome; Epidemiologic Methods; HIV Seropositivity; Humans; Netherlands; Probability; Zidovudine | 1992 |
Bleeding tendency, platelet function, and pharmacokinetics of ibuprofen and zidovudine in HIV(+) hemophilic men.
Topics: Acute Disease; Adolescent; Adult; Bleeding Time; Blood Platelets; Chronic Disease; Drug Therapy, Combination; Hemophilia A; HIV Seropositivity; Humans; Ibuprofen; Male; Platelet Adhesiveness; Platelet Aggregation; Zidovudine | 1992 |
Refusal of zidovudine by HIV-positive patients.
Topics: Adult; Female; HIV Seropositivity; Humans; Male; Middle Aged; Treatment Refusal; Zidovudine | 1992 |
Modulation of alpha interferon levels by AZT treatment in HIV-seropositive patients.
Topics: HIV Antigens; HIV Seropositivity; Humans; Interferon-alpha; Lymphocyte Activation; Zidovudine | 1992 |
Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington S
Topics: Adolescent; Adult; Bone Marrow Transplantation; CD8 Antigens; Clinical Protocols; Combined Modality Therapy; HIV Seropositivity; Humans; Immunotherapy, Adoptive; Lymphoma, AIDS-Related; Middle Aged; T-Lymphocytes, Cytotoxic; Zidovudine | 1992 |
High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Blotting, Southern; Carcinoma, Squamous Cell; Cervix Uteri; Clinical Protocols; Female; HIV Seropositivity; Humans; Middle Aged; Odds Ratio; Papillomaviridae; Risk; Tumor Virus Infections; Uterine Cervical Neoplasms; Zidovudine | 1991 |
Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Cohort Studies; Drug Utilization; Erythrocyte Indices; HIV Seropositivity; Homosexuality; Humans; Male; Multivariate Analysis; United States; Zidovudine | 1991 |
Population-based estimates of zidovudine and aerosol pentamidine use in San Francisco: 1987-1989.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; CD4-Positive T-Lymphocytes; Cohort Studies; Drug Therapy, Combination; HIV Seropositivity; Humans; Leukocyte Count; Male; Pentamidine; San Francisco; Zidovudine | 1991 |
Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction.
Topics: CD4-Positive T-Lymphocytes; HIV; HIV Seropositivity; Humans; Leukocyte Count; Polymerase Chain Reaction; RNA, Viral; Zidovudine | 1991 |
Low number of functionally active B lymphocytes in the peripheral blood of HIV-1-seropositive individuals with low p24-specific serum antibody titers.
Topics: Antibody-Producing Cells; B-Lymphocytes; HIV Antibodies; HIV Core Protein p24; HIV Envelope Protein gp120; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Immunoglobulin G; In Vitro Techniques; Leukocyte Count; Male; RNA-Directed DNA Polymerase; Zidovudine | 1991 |
A patient who got darker on zidovudine therapy.
Topics: Adult; Biopsy; Black People; HIV Seropositivity; Humans; Male; Melanosis; Zidovudine | 1992 |
Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administration.
Topics: DNA, Viral; Follow-Up Studies; HIV; HIV Infections; HIV Seropositivity; Humans; Interleukin-2; Leukocytes, Mononuclear; Polymerase Chain Reaction; Proviruses; Recombinant Proteins; Zidovudine | 1992 |
Pharmacokinetics of single and chronic dose zidovudine in two HIV positive patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Drug Administration Schedule; HIV Seropositivity; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Zidovudine | 1992 |
Prophylaxis with zidovudine (AZT) after exposure to human immunodeficiency virus: a brief discussion of the issues for emergency physicians.
Topics: Animals; Cats; Cost-Benefit Analysis; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Mice; Occupational Exposure; Time Factors; Zidovudine | 1991 |
[Guidelines for the management of the asymptomatic HIV-positive patient in primary care].
Topics: Clinical Protocols; HIV Seropositivity; Humans; Primary Health Care; Zidovudine | 1991 |
CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates.
Topics: Aging; Factor VIII; Follow-Up Studies; Hemophilia A; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; T-Lymphocytes, Helper-Inducer; Transfusion Reaction; Zidovudine | 1991 |
Poor tolerance of zidovudine in an HIV-asymptomatic patient with alpha-thalassemia.
Topics: Adult; Drug Tolerance; Erythrocyte Indices; Female; Hemoglobins; HIV Seropositivity; Humans; Thalassemia; Zidovudine | 1991 |
Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis.
Topics: Adolescent; Adult; Antigens, CD; Child; Child, Preschool; HIV Antigens; HIV Infections; HIV Seropositivity; Humans; Immunoenzyme Techniques; Macrophages; Middle Aged; Myositis; T-Lymphocyte Subsets; Zidovudine | 1991 |
Anorectal surgery in HIV-seropositive patients.
Topics: Anal Canal; HIV Seropositivity; Humans; Postoperative Complications; Rectal Diseases; Rectum; Time Factors; Wound Healing; Zidovudine | 1991 |
Fertility parameters in men infected with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Fertility; HIV; HIV Infections; HIV Seropositivity; Humans; Male; Semen; Sperm Count; Spermatozoa; Zidovudine | 1991 |
Zidovudine in the management of primary HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Blood Cell Count; Drug Administration Schedule; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; T-Lymphocyte Subsets; Viral Core Proteins; Zidovudine | 1991 |
Percutaneous injuries among health care workers. The real value of human immunodeficiency virus testing of 'donor' blood.
Topics: Allied Health Personnel; Blood Donors; Blotting, Western; Decision Trees; Enzyme-Linked Immunosorbent Assay; HIV Infections; HIV Seropositivity; Humans; Mass Screening; Occupational Diseases; Prevalence; Probability; Sensitivity and Specificity; Zidovudine | 1991 |
Epoetin alfa for predialysis and AZT-treated HIV-positive patients.
Topics: Anemia; Erythropoietin; HIV Seropositivity; Humans; Kidney Failure, Chronic; Zidovudine | 1991 |
Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy.
Topics: HIV Infections; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; Lymphocytes; Male; Risk Factors; Semen; Zidovudine | 1991 |
Unraveling the mysteries of vulval ulceration in human immunodeficiency virus-seropositive women.
Topics: Female; HIV Seropositivity; Humans; Ulcer; Vulvar Diseases; Zidovudine | 1991 |
Guidelines for hemophilia care.
Topics: AIDS Serodiagnosis; Blood Coagulation Factors; Child; Female; Hemophilia A; HIV Infections; HIV Seropositivity; Humans; Male; Sexual Partners; Zidovudine | 1991 |
Progression to AIDS among Italian HIV-seropositive haemophiliacs. Italian Group.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Cohort Studies; Hemophilia A; HIV Seropositivity; HIV-1; Humans; Incidence; Infant; Infant, Newborn; Italy; Middle Aged; Prospective Studies; Retrospective Studies; Survival Analysis; Zidovudine | 1991 |
Guidelines for the care of children and adolescents with HIV infection. Medical management in HIV-infected adolescents.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Female; HIV Infections; HIV Seropositivity; Humans; Male; Medical History Taking; Social Support; Zidovudine | 1991 |
Guidelines for the care of children and adolescents with HIV infection. Management of the HIV-positive child with fever.
Topics: Acetaminophen; Acquired Immunodeficiency Syndrome; Child; Fever; HIV Infections; HIV Seropositivity; Humans; Recurrence; Zidovudine | 1991 |
Zidovudine-related thrombocytopenia simulating rapid growth of Kaposi's sarcoma.
Topics: Adult; HIV Seropositivity; Humans; Male; Mouth Neoplasms; Purpura; Sarcoma, Kaposi; Skin Neoplasms; Thrombocytopenia; Zidovudine | 1991 |
Effects of interferon-alpha in patients with AIDS-associated Kaposi's sarcoma are related to blood interferon levels and dose.
Topics: Acquired Immunodeficiency Syndrome; Adult; Dose-Response Relationship, Drug; HIV Seropositivity; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Sarcoma, Kaposi; Zidovudine | 1990 |
A report of eight HIV-seropositive patients with major depression responding to fluoxetine.
Topics: Adult; Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; HIV Seropositivity; Humans; Male; Middle Aged; Pilot Projects; Prognosis; Surveys and Questionnaires; Zidovudine | 1990 |
Michigan physicians to face growing numbers of HIV-positive patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Disease Outbreaks; Female; HIV Seropositivity; Humans; Male; Michigan; Zidovudine | 1990 |
[20-year-old HIV-1-positive hemophiliac patient with conspicuous plantar warts--effects of zidovudine (Retrovir) treatment].
Topics: Adult; Foot Dermatoses; Hemophilia A; HIV Seropositivity; Humans; Male; Warts; Zidovudine | 1990 |
Zidovudine overdose in an intravenous drug user.
Topics: Adult; Female; HIV Seropositivity; Humans; Methadone; Nervous System Diseases; Substance Abuse, Intravenous; Zidovudine | 1990 |
Guidelines for counselling persons who have had an occupational exposure to human immunodeficiency virus.
Topics: Canada; Counseling; Health Workforce; HIV Infections; HIV Seropositivity; Humans; Occupational Diseases; Occupational Exposure; Zidovudine | 1990 |
Public health service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use.
Topics: Canada; Health Workforce; HIV Infections; HIV Seropositivity; Humans; Occupational Diseases; Occupational Exposure; Public Health Administration; Risk Factors; Zidovudine | 1990 |
Symptomatic polyneuropathy in human immunodeficiency virus antibody seropositive men with and without immune deficiency: a comparative electrophysiological study.
Topics: Acquired Immunodeficiency Syndrome; Action Potentials; Adult; HIV Seropositivity; Hot Temperature; Humans; Male; Median Nerve; Neural Conduction; Peroneal Nerve; Physical Stimulation; Polyneuropathies; Sural Nerve; Vibration; Zidovudine | 1990 |
Therapy may explain recent deficits in AIDS incidence.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; HIV Seropositivity; Homosexuality; Humans; Incidence; Male; United States; Zidovudine | 1990 |
Human immunodeficiency virus wasting syndrome may represent a treatable myopathy.
Topics: Acquired Immunodeficiency Syndrome; Adult; HIV Infections; HIV Seropositivity; Humans; Middle Aged; Muscular Diseases; Prednisone; Time Factors; Weight Loss; Zidovudine | 1990 |
Pigmented nail bands and mucocutaneous pigmentation in HIV-positive patients treated with zidovudine.
Topics: Adult; Female; HIV Seropositivity; Humans; Male; Nail Diseases; Pigmentation Disorders; Zidovudine | 1990 |
[The HIV-AIDS situation in Norway].
Topics: Acquired Immunodeficiency Syndrome; Female; HIV Infections; HIV Seropositivity; Humans; Male; Norway; Zidovudine | 1990 |
Zidovudine approved for use in children.
Topics: Child; Child, Preschool; HIV Seropositivity; Humans; Infant; United States; United States Food and Drug Administration; Zidovudine | 1990 |
Vulvar ulcer of unknown etiology in a human immunodeficiency virus-infected woman: response to treatment with zidovudine.
Topics: Adult; Female; HIV Seropositivity; Humans; Male; Ulcer; Vulvar Diseases; Zidovudine | 1990 |
AIDS encephalopathy with response to treatment.
Topics: Antiviral Agents; Brain Diseases; Child, Preschool; gamma-Globulins; HIV Seropositivity; Humans; Male; Opportunistic Infections; Thymidine; Zidovudine | 1988 |
T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Differentiation, T-Lymphocyte; HIV Seropositivity; Humans; Lymphocyte Activation; Male; Sexual Behavior; T-Lymphocytes; Tuberculin; Viral Envelope Proteins; Zidovudine | 1989 |
Rape and seroconversion.
Topics: Female; HIV Seropositivity; Humans; Immunization, Passive; Immunoglobulins; Rape; Zidovudine | 1989 |
Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus.
Topics: Adult; Candidiasis; Dermatitis, Seborrheic; HIV Seropositivity; Homosexuality; Humans; Injections, Intravenous; Ketoconazole; Male; Middle Aged; Skin Diseases; Substance-Related Disorders; Zidovudine | 1989 |
Seizure after zidovudine overdose.
Topics: Adult; Epilepsy, Tonic-Clonic; HIV Seropositivity; Humans; Male; Zidovudine | 1989 |
Influence of zidovudine on progression to AIDS in cohort studies.
Topics: Acquired Immunodeficiency Syndrome; Cohort Studies; Drug Evaluation; Follow-Up Studies; HIV Seropositivity; Humans; Male; Time Factors; Zidovudine | 1989 |
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.
Topics: Acquired Immunodeficiency Syndrome; Follow-Up Studies; HIV; HIV Seropositivity; Humans; Longitudinal Studies; Male; Retrospective Studies; Risk Factors; T-Lymphocytes; Time Factors; Virus Replication; Zidovudine | 1989 |
Phase I study of low-dose zidovudine and acyclovir in asymptomatic human immunodeficiency virus seropositive individuals.
Topics: Acyclovir; Adult; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Drug Synergism; Erythrocyte Count; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; Male; Metabolic Clearance Rate; Middle Aged; Monocytes; Zidovudine | 1989 |
Zidovudine therapy in HIV-related thrombocytopenia.
Topics: Female; HIV Seropositivity; Humans; Middle Aged; Platelet Count; Thrombocytopenia; Zidovudine | 1989 |
Effects of 3-azidothymidine on platelet counts, indium-111-labelled platelet kinetics, and antiplatelet antibodies.
Topics: Autoantibodies; Blood Platelets; Complement C3; Complement C3d; Fluorescent Antibody Technique; Hemophilia A; HIV Seropositivity; Humans; Immunoglobulin G; Immunoglobulin M; Indium Radioisotopes; Kinetics; Platelet Count; Precipitin Tests; Prospective Studies; Zidovudine | 1989 |
Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody.
Topics: Acquired Immunodeficiency Syndrome; Cells, Cultured; HIV; HIV Antibodies; HIV Seropositivity; Humans; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Virus Replication; Zidovudine | 1989 |
Serum immunoreactive erythropoietin in HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Complex; Anemia; Blood Cell Count; Erythropoietin; Female; Hemoglobins; HIV Seropositivity; Humans; Longitudinal Studies; Male; Radioimmunoassay; Zidovudine | 1989 |
Zidovudine-related mania.
Topics: Adult; Bipolar Disorder; HIV Seropositivity; Humans; Male; Middle Aged; Zidovudine | 1989 |
Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection.
Topics: Administration, Oral; Chromatography, High Pressure Liquid; Hemophilia A; HIV; HIV Seropositivity; Humans; Liver Function Tests; Male; Metabolic Clearance Rate; Zidovudine | 1989 |
Pathophysiology of thrombocytopenia associated with HIV infection in homosexual men. A preliminary report.
Topics: Acquired Immunodeficiency Syndrome; Autoimmune Diseases; Blood Platelets; Cell Survival; HIV Seropositivity; Homosexuality; Humans; Male; Platelet Count; Thrombocytopenia; Zidovudine | 1989 |
[Retrovir].
Topics: Acquired Immunodeficiency Syndrome; HIV Seropositivity; Humans; Zidovudine | 1989 |
Testing source patient blood for HIV antibodies after accidental exposure of health care workers to blood and body fluids.
Topics: Acquired Immunodeficiency Syndrome; Body Fluids; Environmental Exposure; HIV Antibodies; HIV Seropositivity; Humans; Patient Care Team; Zidovudine | 1989 |
[HIV and the central nervous system].
Topics: Encephalitis; HIV Seropositivity; Humans; Zidovudine | 1989 |
Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (G.AZT) in healthy subjects and HIV seropositive patients.
Topics: Adult; HIV Seropositivity; Humans; Male; Middle Aged; Zidovudine | 1989 |
The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antibodies, Viral; HIV Seropositivity; Homosexuality; Humans; Immunization, Secondary; Influenza Vaccines; Influenza, Human; Leukocyte Count; T-Lymphocytes; Vaccines, Inactivated; Zidovudine | 1989 |
Relevance of computed tomography to diagnose Pneumocystis carinii pneumonia.
Topics: Adult; HIV Seropositivity; Humans; Male; Pneumonia, Pneumocystis; Tomography, X-Ray Computed; Zidovudine | 1989 |
In vitro synthesis of human immunodeficiency virus-specific antibodies in peripheral blood lymphocytes of infants.
Topics: Acquired Immunodeficiency Syndrome; Adult; B-Lymphocytes; Cells, Cultured; Child; Enzyme-Linked Immunosorbent Assay; HIV Antibodies; HIV Seropositivity; Humans; Immunoglobulin G; Infant; Infant, Newborn; Kinetics; Lymphocytes; Zidovudine | 1989 |
[HIV seropositive patients no longer fit to drive? Silent encephalitis--early therapy with AZT?].
Topics: AIDS Dementia Complex; Automobile Driving; HIV Seropositivity; Humans; Zidovudine | 1989 |
[Nail pigmentation caused by azidothymidine].
Topics: Hemophilia A; HIV Seropositivity; Humans; Male; Middle Aged; Nail Diseases; Pigmentation Disorders; Zidovudine | 1989 |
Perinatal pharmacokinetics of zidovudine.
Topics: Female; Fetus; HIV Seropositivity; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1989 |
AIDS: AZT for children in extended US trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Child; HIV Seropositivity; Humans; United States; United States Food and Drug Administration; Zidovudine | 1989 |
Zidovudine experience at the Hospitals for Sick Children, Great Ormond Street, London.
Topics: Acquired Immunodeficiency Syndrome; Child; Child, Preschool; Hemophilia A; HIV Seropositivity; Humans; London; Male; Zidovudine | 1989 |
Use of zidovudine for drug misusers infected with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Interactions; Female; HIV Seropositivity; Humans; Injections, Intravenous; Male; Middle Aged; Narcotics; Patient Compliance; Substance-Related Disorders; Zidovudine | 1989 |
Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection.
Topics: Adult; Aged; Female; HIV Seropositivity; Humans; Male; Middle Aged; Pilot Projects; Platelet Count; Purpura, Thrombocytopenic; Zidovudine | 1989 |
[AZT therapy. Success in HIV-infected children].
Topics: Acquired Immunodeficiency Syndrome; Child; HIV Seropositivity; Humans; Prognosis; Zidovudine | 1989 |
The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antibodies, Viral; Antiviral Agents; Hemagglutination Inhibition Tests; HIV Core Protein p24; HIV Seropositivity; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Leukocyte Count; Male; Prospective Studies; Retroviridae Proteins; T-Lymphocytes, Helper-Inducer; Thymidine; Viral Core Proteins; Zidovudine | 1988 |
[Blood histamine levels in patients infected with the human immunodeficiency virus].
Topics: Histamine; HIV Seropositivity; Humans; Purpura, Thrombocytopenic; Splenectomy; Time Factors; Zidovudine | 1988 |
Treating HIV positive haemophiliacs with zidovudine.
Topics: Hemophilia A; HIV Seropositivity; Humans; Zidovudine | 1988 |
Treating HIV positive haemophiliacs with zidovudine.
Topics: Hemophilia A; HIV Seropositivity; Humans; Risk Assessment; Therapeutic Human Experimentation; Zidovudine | 1988 |
[The child with HIV infection and the child with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Child; Child, Preschool; HIV Seropositivity; Humans; Immunization, Passive; Pediatric Nursing; Zidovudine | 1988 |
The effect of zidovudine on antigen levels in HIV infection.
Topics: Acyclovir; Antigens, Viral; Antiviral Agents; Drug Therapy, Combination; HIV; HIV Antigens; HIV Seropositivity; Humans; Male; Thymidine; Zidovudine | 1988 |
Infants of women seropositive for HIV.
Topics: Female; HIV Seropositivity; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal Exchange; Pregnancy; Zidovudine | 1988 |
Combination treatment of wellferon and zidovudine in asymptomatic HIV p24 Ag positive patients.
Topics: Combined Modality Therapy; HIV Seropositivity; Humans; Interferon Type I; Zidovudine | 1988 |
[Plasma exchange in polyradiculoneuritis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Ganciclovir; HIV Seropositivity; Humans; Male; Middle Aged; Plasma Exchange; Polyradiculoneuropathy; Zidovudine | 1988 |
Factitious false-positive test for HIV.
Topics: Adult; Factitious Disorders; False Positive Reactions; HIV Seropositivity; Humans; Male; Thymidine; Zidovudine | 1988 |